<SEC-DOCUMENT>0000950123-11-031659.txt : 20110401
<SEC-HEADER>0000950123-11-031659.hdr.sgml : 20110401
<ACCEPTANCE-DATETIME>20110331184244
ACCESSION NUMBER:		0000950123-11-031659
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		5
CONFORMED PERIOD OF REPORT:	20110330
ITEM INFORMATION:		Non-Reliance on Previously Issued Financial Statements or a Related Audit Report or Completed Interim Review
ITEM INFORMATION:		Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20110401
DATE AS OF CHANGE:		20110331

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Cyclacel Pharmaceuticals, Inc.
		CENTRAL INDEX KEY:			0001130166
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				911766850
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-50626
		FILM NUMBER:		11728073

	BUSINESS ADDRESS:	
		STREET 1:		200 CONNELL DRIVE
		STREET 2:		SUITE 1500
		CITY:			BERKELEY HEIGHTS
		STATE:			NJ
		ZIP:			07922
		BUSINESS PHONE:		908-517-7330

	MAIL ADDRESS:	
		STREET 1:		200 CONNELL DRIVE
		STREET 2:		SUITE 1500
		CITY:			BERKELEY HEIGHTS
		STATE:			NJ
		ZIP:			07922

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	XCYTE THERAPIES INC
		DATE OF NAME CHANGE:	20001218
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>c14970e8vk.htm
<DESCRIPTION>8-K
<TEXT>
<HTML>
<HEAD>
<TITLE>8-K</TITLE>
</HEAD>
<BODY bgcolor="#FFFFFF">
<!-- PAGEBREAK -->
<DIV style="width: 7.5in; font-family: 'Times New Roman',Times,serif; margin-left: 0.25in">
<DIV style="font-size: 10pt">
<DIV style="border-bottom: black 2pt solid; width: 100%; font-size: 1pt">&nbsp;</DIV>
<DIV style="border-bottom: black 1pt solid; width: 100%; font-size: 1pt">&nbsp;</DIV>

<P style="font-size: 14pt" align="center"><B>UNITED STATES<BR>
SECURITIES AND EXCHANGE COMMISSION<BR>
<FONT style="font-size: 12pt">Washington, D.C. 20549
</FONT></B>

<P style="font-size: 18pt" align="center"><B>FORM 8-K</B>

<P style="font-size: 12pt" align="center"><B>CURRENT REPORT<BR>
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934</B>

<P style="font-size: 10pt" align="center"><B>Date of Report (Date of earliest event reported): March 30, 2011</B>

<P style="font-size: 24pt" align="center"><B>CYCLACEL PHARMACEUTICALS, INC.<BR>
</B><FONT style="font-size: 10pt">(Exact name of registrant as specified in its charter) </FONT>
<TABLE style="text-align: center; font-size: 10pt" border="0" cellspacing="0" cellpadding="0" width="100%">
 <TR>
  <TD width="32%">&nbsp;</TD>
  <TD width="1%">&nbsp;</TD>
  <TD width="33%">&nbsp;</TD>
  <TD width="1%">&nbsp;</TD>
  <TD width="32%">&nbsp;</TD>
 </TR>
 <TR valign="bottom">
  <TD style="border-bottom: #000000 1px solid"><B>Delaware</B></TD>
  <TD>&nbsp;</TD>
  <TD style="border-bottom: #000000 1px solid"><B>0-50626</B></TD>
  <TD>&nbsp;</TD>
  <TD style="border-bottom: #000000 1px solid"><B>91-1707622</B></TD>
 </TR>
 <TR valign="top">
  <TD>(State or other Jurisdiction of Incorporation)</TD>
  <TD>&nbsp;</TD>
  <TD>(Commission File Number)</TD>
  <TD>&nbsp;</TD>
  <TD>(IRS Employer Identification No.)</TD>
 </TR>
</TABLE>

<TABLE style="text-align: center; font-size: 10pt" border="0" cellspacing="0" cellpadding="0" width="100%">
 <TR>
  <TD width="49%">&nbsp;</TD>
  <TD width="1%">&nbsp;</TD>
  <TD width="49%">&nbsp;</TD>
 </TR>
 <TR valign="bottom">
  <TD style="border-bottom: #000000 1px solid"><B>200 Connell Drive, Suite 1500<BR>
Berkeley Heights, NJ<BR>
</B></TD>
  <TD>&nbsp;</TD>
  <TD style="border-bottom: #000000 1px solid"><B>07922</B></TD>
 </TR>
 <TR valign="top">
  <TD>(Address of Principal Executive Offices)</TD>
  <TD>&nbsp;</TD>
  <TD>(Zip Code)</TD>
 </TR>
</TABLE>


<P style="font-size: 10pt" align="center">Registrant&#8217;s telephone number, including area code: <B>(908) 517-7330</B>

<TABLE style="text-align: center; font-size: 10pt" border="0" cellspacing="0" cellpadding="0" width="30%">
 <TR>
  <TD width="100%">&nbsp;</TD>
 </TR>
 <TR>
  <TD style="border-bottom: #000000 1px solid" nowrap><B>&nbsp;</B></TD>
 </TR>
 <TR>
  <TD nowrap>(Former name or former address if changed since last report.)</TD>
 </TR>
</TABLE>


<P style="font-size: 10pt" align="left">Check the appropriate box below if the
Form 8-K filing is intended to simultaneously satisfy the filing obligation of
the registrant under any of the following provisions:

<P style="font-size: 10pt" align="left"><FONT face="Wingdings">o</FONT> Written
communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)<BR>
<BR>
<FONT face="Wingdings">o</FONT> Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)<BR>
<BR>
<FONT face="Wingdings">o</FONT> Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))<BR>
<BR>
<FONT face="Wingdings">o</FONT> Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))<BR>


<DIV style="border-bottom: black 1pt solid; margin-top: 10pt; width: 100%; font-size: 1pt">&nbsp;</DIV>
<DIV style="border-bottom: black 2pt solid; width: 100%; font-size: 1pt">&nbsp;</DIV>
</DIV>

<P style="font-size: 10pt" align="center">

<P style="display: none; font-size: 10pt" align="center">1
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="width: 7.5in; font-family: 'Times New Roman',Times,serif; margin-left: 0.25in">

<P style="font-size: 10pt" align="left"><B>Item&nbsp;4.02 Non-Reliance on
Previously Issued Financial Statements or a Related Audit Report or Completed Interim Review.</B>

<P style="font-size: 10pt" align="left">(a)&nbsp;On March&nbsp;30, 2011, the
Board of Directors of Cyclacel Pharmaceuticals, Inc. (the
&#8220;<B>Company</B>&#8221;), based on the recommendation of its Audit
Committee and in consultation with management, has concluded that the following
previously issued consolidated financial statements must be restated and should
no longer be relied upon because the Company erroneously accrued and included
as a current liability its undeclared cumulative preferred stock dividends in
such financial statements:

<P>
<TABLE style="font-size: 10pt" border="0" cellspacing="0" cellpadding="0" width="100%">
 <TR style="background: none transparent scroll repeat 0% 0%; color: #000000; font-size: 10pt" valign="top">
  <TD style="background: none transparent scroll repeat 0% 0%" width="2%">&nbsp;</TD>
  <TD width="3%" nowrap align="left">i.</TD>
  <TD width="1%">&nbsp;</TD>
  <TD>consolidated balance sheets as of March&nbsp;31, 2009, June&nbsp;30,
2009, September&nbsp;30, 2009, December&nbsp;31, 2009, March&nbsp;31, 2010,
June&nbsp;30, 2010, and September&nbsp;30, 2010 and consolidated statement of
stockholders&#8217; equity for the year ended December&nbsp;31, 2009; and</TD>
 </TR>
</TABLE>


<P>
<TABLE style="font-size: 10pt" border="0" cellspacing="0" cellpadding="0" width="100%">

 <TR style="background: none transparent scroll repeat 0% 0%; color: #000000; font-size: 10pt" valign="top">
  <TD style="background: none transparent scroll repeat 0% 0%" width="2%">&nbsp;</TD>
  <TD width="3%" nowrap align="left">ii.</TD>
  <TD width="1%">&nbsp;</TD>
  <TD>Selected Financial Data as of and for the year ended December&nbsp;31, 2009.</TD>
 </TR>
</TABLE>


<P style="text-indent: 2%; font-size: 10pt" align="left">As a result, in its
Annual Report on Form 10-K for the year ending December&nbsp;31, 2010, the Company:

<P>
<TABLE style="font-size: 10pt" border="0" cellspacing="0" cellpadding="0" width="100%">
 <TR style="background: none transparent scroll repeat 0% 0%; color: #000000; font-size: 10pt" valign="top">
  <TD style="background: none transparent scroll repeat 0% 0%" width="2%">&nbsp;</TD>
  <TD width="3%" nowrap align="left">i.</TD>
  <TD width="1%">&nbsp;</TD>
  <TD>restated its consolidated balance sheet as of December&nbsp;31, 2009 and
its consolidated statement of stockholders&#8217; equity for the year ended
December&nbsp;31, 2009;</TD>
 </TR>
</TABLE>


<P>
<TABLE style="font-size: 10pt" border="0" cellspacing="0" cellpadding="0" width="100%">
 <TR style="background: none transparent scroll repeat 0% 0%; color: #000000; font-size: 10pt" valign="top">
  <TD style="background: none transparent scroll repeat 0% 0%" width="2%">&nbsp;</TD>
  <TD width="3%" nowrap align="left">ii.</TD>
  <TD width="1%">&nbsp;</TD>
  <TD>amended its Management&#8217;s Discussion and Analysis of Financial
Condition and Results of Operations (&#8220;<B>MD&amp;A</B>&#8221;) as it
relates to the year ended December&nbsp;31, 2009;</TD>
 </TR>
</TABLE>


<P>
<TABLE style="font-size: 10pt" border="0" cellspacing="0" cellpadding="0" width="100%">
 <TR style="background: none transparent scroll repeat 0% 0%; color: #000000; font-size: 10pt" valign="top">
  <TD style="background: none transparent scroll repeat 0% 0%" width="2%">&nbsp;</TD>
  <TD width="3%" nowrap align="left">iii.</TD>
  <TD width="1%">&nbsp;</TD>
  <TD>restated its Selected Financial Data as of and for the year ended December&nbsp;31, 2009; and</TD>
 </TR>
</TABLE>


<P>
<TABLE style="font-size: 10pt" border="0" cellspacing="0" cellpadding="0" width="100%">
 <TR style="background: none transparent scroll repeat 0% 0%; color: #000000; font-size: 10pt" valign="top">
  <TD style="background: none transparent scroll repeat 0% 0%" width="2%">&nbsp;</TD>
  <TD width="3%" nowrap align="left">iv.</TD>
  <TD width="1%">&nbsp;</TD>
  <TD>restated its unaudited consolidated balance sheets as of March&nbsp;31,
2009, June&nbsp;30, 2009, September&nbsp;30, 2009, March&nbsp;31, 2010,
June&nbsp;30, 2010, and September&nbsp;30, 2010.</TD>
 </TR>
</TABLE>


<P style="text-indent: 4%; font-size: 10pt" align="left">The Company&#8217;s
management and the Audit Committee of the Company&#8217;s Board of Directors
have discussed these matters disclosed in this Current Report on Form 8-K with
the Company&#8217;s independent registered public accounting firm.

<P style="text-indent: 4%; font-size: 10pt" align="left">As a result of the decision to restate,
the Company was informed by Ernst &#038; Young LLP in a letter dated March&nbsp;31, 2011 that it
was withdrawing its audit reports on the consolidated financial statements included in the
Company&#146;s Annual Report on Form 10-K/A for the year ended December&nbsp;31, 2009.  Such
withdrawal is required by the standards of the Public Company Accounting Oversight Board (U.S.).

<P style="font-size: 10pt" align="left"><B>Background on the Restatement</B>

<P style="text-indent: 2%; font-size: 10pt" align="left">The restated financial
statements correct the following error:

<P style="font-size: 10pt" align="left"><I>Undeclared Preferred Stock Dividends</I>

<P style="text-indent: 4%; font-size: 10pt" align="left">In March&nbsp;2011,
the Company became aware of an error with respect to the historical accounting
for undeclared dividends associated with the Company&#8217;s outstanding
preferred stock. The Company&#8217;s management reviewed this interpretation
and determined that undeclared cumulative preferred stock dividends need only
be disclosed in the financial statements or in the notes thereto, and not
accrued and included as a current liability in the Company&#8217;s consolidated
balance sheets, as the Company had recorded in prior periods. The effect of
correcting the error has been recorded in the applicable restated periods.

<P style="text-indent: 4%; font-size: 10pt" align="left">The effects of the
restatement did not affect the Company&#8217;s results of operations, reported
loss per share, or cash flows.

<P style="text-indent: 4%; font-size: 10pt" align="left">The adjustments made
as a result of the restatement are also being discussed in Note 3 &#175;
&#8220;Restatement of Previously Issued Financial Statements&#8221;, of the
Notes to Consolidated Financial Statements included in the Company&#8217;s
Annual Report on Form 10-K. Quarterly reports for the year ended
December&nbsp;31, 2011 will include restated consolidated balance sheets for
the corresponding interim periods of 2010.

<P style="text-indent: 4%; font-size: 10pt" align="left">The Company has not
amended and does not intend to amend its previously filed Annual Reports on
Form 10-K and Quarterly Reports on Form 10-Q for the periods affected by the
restatement. The information that has been previously filed or otherwise
reported for these periods was restated and superseded by the information in
the Annual Report on From 10-K for the year ended December&nbsp;31, 2010. As
such, the consolidated financial statements and related financial information
contained in such previously filed reports should no longer be relied upon, nor
should any earnings releases or other communications relating to the
Company&#8217;s financial performance during these periods be relied upon.

<P style="text-indent: 4%; font-size: 10pt" align="center">

<P style="display: none; font-size: 10pt" align="center">2
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="width: 7.5in; font-family: 'Times New Roman',Times,serif; margin-left: 0.25in">

<P style="text-indent: 4%; font-size: 10pt" align="left">Management has
concluded that, as of December&nbsp;31, 2010, the Company&#8217;s disclosure
controls and procedures were ineffective at the reasonable assurance level and
the Company&#8217;s internal controls over financial reporting were ineffective
based on the criteria established in Internal Control &#8211; Integrated
Framework issued by the Committee of Sponsoring Organizations of the Treadway
Commission, because the Company did not have an effectively-designed control in
operation over the accounting for, presentation of and disclosure of cumulative
preferred stock dividends to prevent or detect on a timely basis material
misstatements, specifically
with respect to the Company&#8217;s undeclared cumulative preferred stock
dividends that had been accrued and included as a current liability in the
Company&#8217;s consolidated balance sheets.

<P style="text-indent: 4%; font-size: 10pt" align="left">On March&nbsp;31,
2011, the Company issued a press release, a copy of which is attached hereto as
Exhibit&nbsp;99.1, announcing that its the consolidated financial statements as
of and for the year ended December&nbsp;31, 2009 and quarterly consolidated
financials statements for each of the three months ended March&nbsp;31,
June&nbsp;30 and September&nbsp;30, 2010 will be restated to correct the error
described above.

<P style="font-size: 10pt" align="left"><B>Item&nbsp;5.03 Amendments to
Articles of Incorporation or Bylaws; Change in Fiscal Year.</B>

<P style="text-indent: 4%; font-size: 10pt" align="left">On March&nbsp;30,
2011, the Company&#8217;s Board of Directors approved an amendment to the
Amended and Restated Bylaws (the &#8220;<B>Amendment</B>&#8221;) of the Company
to clarify that where a separate vote by a class or series or classes or series
is required, a majority of the outstanding shares of such class or series or
classes or series, present in person or represented by proxy,
shall&nbsp;constitute a quorum entitled to take action with respect to that
vote on the matter.

<P style="text-indent: 4%; font-size: 10pt" align="left">A copy of the
Amendment is attached hereto as Exhibit&nbsp;3.01 and is incorporated herein by
reference.

<P style="font-size: 10pt" align="left"><B>Item&nbsp;9.01 Financial Statements and Exhibits.</B>

<P style="font-size: 10pt" align="left">(d)&nbsp;Exhibits.

<DIV align="center">
<TABLE style="font-size: 10pt" border="0" cellspacing="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
 <TR valign="bottom">
  <TD width="8%">&nbsp;</TD>
  <TD width="5%">&nbsp;</TD>
  <TD width="87%">&nbsp;</TD>
 </TR>
<TR style="font-size: 10pt" valign="bottom">
  <TD nowrap align="left"><B>Exhibit</B></TD>
  <TD>&nbsp;</TD>
  <TD>&nbsp;</TD>
</TR>
<TR style="font-size: 10pt" valign="bottom">
  <TD style="border-bottom: #000000 1px solid" nowrap align="left"><B>Number</B></TD>
  <TD>&nbsp;</TD>
  <TD style="border-bottom: #000000 1px solid" nowrap align="left"><B>Description</B></TD>
</TR>
<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom">
  <TD valign="top"><DIV style="text-indent: 0px; margin-left: 0px">3.01 </DIV></TD>
  <TD>&nbsp;</TD>
  <TD valign="top" align="left">Amendment No.&nbsp;2 to the Amended and
Restated Bylaws of Cyclacel Pharmaceuticals, Inc.</TD>
</TR>

<TR valign="bottom">
  <TD valign="top"><DIV style="text-indent: 0px; margin-left: 0px">99.1</DIV></TD>
  <TD>&nbsp;</TD>
  <TD valign="top" align="left">Press release dated March&nbsp;31,
2011, announcing the restatement of and non-reliance on 2009 annual and 2010 quarterly financial statements.</TD>
</TR>

<!-- End Table Body -->
</TABLE>
</DIV>

<P style="font-size: 10pt" align="center">

<P style="display: none; font-size: 10pt" align="center">3
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="width: 7.5in; font-family: 'Times New Roman',Times,serif; margin-left: 0.25in">

<P style="font-size: 10pt" align="center"><B>SIGNATURES</B>

<P style="text-indent: 4%; font-size: 10pt" align="left">Pursuant to the
requirements of the Securities Exchange Act of 1934, the Registrant has duly
caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

<P style="margin-left: 56%; font-size: 10pt" align="left"><B>CYCLACEL PHARMACEUTICALS, INC.</B>

<P style="margin-left: 56%; font-size: 10pt" align="left">By: <U>/s/
Paul McBarron&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U><BR>
Name: Paul McBarron<BR>
Title: Executive Vice President&#8212;Finance,<BR>
Chief Financial Officer and<BR>
Chief Operating Officer<BR>


<P style="font-size: 10pt" align="left">Date: March&nbsp;31, 2011

<P style="font-size: 10pt" align="center">

<P style="display: none; font-size: 10pt" align="center">4
</DIV>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-3.01
<SEQUENCE>2
<FILENAME>c14970exv3w01.htm
<DESCRIPTION>EXHIBIT 3.01
<TEXT>
<HTML>
<HEAD>
<TITLE>Exhibit 3.01</TITLE>
</HEAD>
<BODY bgcolor="#FFFFFF">
<!-- PAGEBREAK -->

<DIV style="width: 7.5in; font-family: 'Times New Roman',Times,serif; margin-left: 0.25in">

<P style="font-size: 10pt" align="right"><B>Exhibit&nbsp;3.01</B>

<P style="font-size: 10pt" align="center"><B>CYCLACEL PHARMACEUTICALS, INC.</B>

<P style="font-size: 10pt" align="center"><B>AMENDMENT NO. 2<BR>
TO THE AMENDED AND RESTATED BYLAWS</B>

<P style="text-indent: 4%; font-size: 10pt" align="left">The following
Amendment No.&nbsp;2 (this &#8220;<B>Amendment</B>&#8221;) to the Amended and
Restated Bylaws (the &#8220;<B>Bylaws</B>&#8221;) of Cyclacel Pharmaceuticals,
Inc., a Delaware corporation (the &#8220;<B>Corporation</B>&#8221;), has been
duly authorized, approved, and adopted by the Board of Directors of the
Corporation in accordance with the provisions of Section&nbsp;242 of the
General Corporation Law of the State of Delaware:

<P style="font-size: 10pt" align="left">1.&nbsp;<U>Amendment</U>. The Bylaws of
Cyclacel Pharmaceuticals, Inc., a Delaware corporation (the
&#8220;<B>Corporation</B>&#8221;), are hereby amended by striking out
Section&nbsp;2.6 thereof and by substituting in lieu of said Section the
following new Section&nbsp;2.6:

<P style="text-indent: 4%; font-size: 10pt" align="left">2.6 <U><B>Quorum</B></U>.

<P style="text-indent: 8%; font-size: 10pt" align="left">The holders of a
majority of the shares of stock issued and outstanding and entitled to vote
thereat, present in person or represented by proxy, shall constitute a quorum
at all meetings of the stockholders for the transaction of business except as
otherwise provided by statute or by the Certificate of Incorporation. Where a
separate vote by a class or series or classes or series is required, a majority
of the outstanding shares of such class or series or classes or series, present
in person or represented by proxy, shall&nbsp;constitute a quorum entitled to
take action with respect to that vote on the matter. If, however, such quorum
is not present or represented at any meeting of the stockholders, then either
(a)&nbsp;the chairman of the meeting or (b)&nbsp;holders of a majority of the
shares of stock entitled to vote who are present, in person or by proxy, shall
have power to adjourn the meeting to another place (if any), date or time.

<P style="font-size: 10pt" align="left">2.&nbsp;<U>Effect of Amendment</U>.
Except as amended by this Amendment, the Bylaws shall remain in full force and
effect in accordance with their terms. From and after the date hereof, all
references made in the Bylaws to the Bylaws shall be a reference to the Bylaws
as amended by this Amendment.

<P style="font-size: 10pt" align="left">Signed this 30th day of March, 2011

<P style="margin-left: 46%; font-size: 10pt" align="left">Cyclacel Pharmaceuticals, Inc.

<P style="margin-left: 46%; font-size: 10pt" align="left">By: <U>/s/
Paul McBarron&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U><BR>
Name: Paul McBarron<BR>
Title: Executive Vice President&#8212;Finance,<BR>
Chief Financial Officer and<BR>
Chief Operating Officer<BR>


<P style="font-size: 10pt" align="center">

<P style="display: none; font-size: 10pt" align="center">5
</DIV>
</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>3
<FILENAME>c14970exv99w1.htm
<DESCRIPTION>EXHIBIT 99.1
<TEXT>
<HTML>
<HEAD>
<TITLE>Exhibit 99.1</TITLE>
</HEAD>
<BODY bgcolor="#FFFFFF">
<!-- PAGEBREAK -->
<DIV style="width: 7.5in; font-family: Arial,sans-serif; margin-left: 0.25in">

<P style="font-size: 10pt" align="right">Exhibit&nbsp;99.1

<P style="font-size: 10pt" align="center"><IMG src="c14970p1497001.jpg">

<P style="font-size: 10pt" align="center"><B>CYCLACEL PHARMACEUTICALS TO RESTATE 2009 ANNUAL AND 2010 QUARTERLY FINANCIAL STATEMENTS TO CORRECT CONSOLIDATED BALANCE SHEETS AND CONSOLIDATED STATEMENT OF
STOCKHOLDERS&#8217; EQUITY; NO IMPACT ON RESULTS OF OPERATIONS.</B>

<P style="font-size: 10pt" align="justify"><B>Berkeley Heights, NJ,
March&nbsp;31, 2011 </B>&#8211; Cyclacel Pharmaceuticals, Inc. (NASDAQ: CYCC,
NASDAQ: CYCCP; Cyclacel or the Company), announced today that the
Company&#8217;s consolidated financial statements as of and for the year ended
December&nbsp;31, 2009 and quarterly consolidated financials statements for
each of the three months ended March&nbsp;31, June&nbsp;30 and
September&nbsp;30, 2010 (the &#8220;Financial Statements&#8221;) contained in
its Annual Report on Form 10-K filed with the Securities and Exchange
Commission on March&nbsp;31, 2011 (the &#8220;Annual Report&#8221;) have been
restated to correct an error with respect to the recognition of undeclared
cumulative preferred stock dividends as it relates to the payment of dividends
on the Company&#8217;s 6% Convertible Exchangeable Preferred Stock (the
&#8220;Preferred Stock&#8221;) and disclosures in the consolidated balance
sheets and consolidated statement of stockholders&#8217; equity related to the
dividends on the Preferred Stock.

<P style="font-size: 10pt" align="justify">The effects of the restatement did
not in any way affect the Company&#8217;s results of operations, reported loss
per share, or cash flows.

<P style="font-size: 10pt" align="justify">In March&nbsp;2011, the Company
became aware of an error with respect to the historical accounting for
undeclared dividends associated with our outstanding preferred stock. The
Company&#8217;s management reviewed the error and determined that undeclared
cumulative preferred stock dividends need only be disclosed in the financial
statements or in the notes thereto, and not accrued and included as a current
liability in the Company&#8217;s consolidated balance sheets, as the Company
had recorded in prior periods. The effect of correcting the error has been
recorded in the applicable restated periods. For the year ended
December&nbsp;31, 2009, accrued and other current liabilities were revised from
$6.7&nbsp;million to $5.5&nbsp;million. For the quarters ended March&nbsp;31,
2009, June&nbsp;30, 2009 and September&nbsp;30, 2009 other current liabilities
were revised from $0.6&nbsp;million, $0.8&nbsp;million and $1.3&nbsp;million to
$0.3&nbsp;million, $0.2&nbsp;million and $0.4&nbsp;million, respectively. For
the quarters ended March&nbsp;31, 2010, June&nbsp;30, 2010 and
September&nbsp;30, 2010 accrued and other current liabilities were revised from
$5.8&nbsp;million, $5.3&nbsp;million and $5.6&nbsp;million to
$4.4&nbsp;million, $4.2&nbsp;million and $4.4 million, respectively.

<P style="font-size: 10pt" align="justify"><B>About Cyclacel Pharmaceuticals, Inc.</B>

<P style="font-size: 10pt" align="justify">Cyclacel is a biopharmaceutical
company developing oral therapies that target the various phases of cell cycle
control for the treatment of cancer and other serious diseases. Sapacitabine
(CYC682), a cell cycle modulating nucleoside analog, is in Phase 3 development
for the treatment of acute myeloid leukemia in the elderly under a Special
Protocol Assessment agreement with the U.S. Food and Drug Administration, and
in Phase 2 studies for myelodysplastic syndromes and lung cancer. Seliciclib
(CYC202 or R-roscovitine), a CDK (cyclin dependent kinase) inhibitor, is in
Phase 2 studies for the treatment of lung cancer and nasopharyngeal cancer and
in a Phase 1 trial in combination with sapacitabine. Cyclacel&#8217;s ALIGN
Pharmaceuticals subsidiary markets directly in the U.S. Xclair&#174; Cream for
radiation dermatitis, Numoisyn&#174; Liquid and Numoisyn&#174; Lozenges for
xerostomia. Cyclacel&#8217;s strategy is to build a diversified
biopharmaceutical business focused in hematology and oncology based on a
portfolio of commercial products and a development pipeline of novel drug
candidates. Please visit <U>www.cyclacel.com</U> for additional information.

<P style="font-size: 10pt" align="center"><IMG src="c14970p1497002.jpg">

<P style="font-size: 10pt" align="center">

<P style="display: none; font-size: 10pt" align="center">1
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="width: 7.5in; font-family: Arial,sans-serif; margin-left: 0.25in">

<P style="font-size: 10pt" align="center">2

<P style="font-size: 10pt" align="center"><B>Forward-looking Statements</B>

<P style="font-size: 10pt" align="justify">This news release contains certain
forward-looking statements that involve risks and uncertainties that could
cause actual results to be materially different from historical results or from
any future results expressed or implied by such forward-looking statements.
Such forward-looking statements include statements regarding, among other
things, the efficacy, safety, and intended utilization of Cyclacel&#8217;s
product candidates, the conduct and results of future clinical trials, plans
regarding regulatory filings, future research and clinical trials and plans
regarding partnering activities. Factors that may cause actual results to
differ materially include the risk that product candidates that appeared
promising in early research and clinical trials do not demonstrate safety
and/or efficacy in larger-scale or later clinical trials, the risk that
Cyclacel will not obtain approval to market its products, the risks associated
with reliance on outside financing to meet capital requirements, and the risks
associated with reliance on collaborative partners for further clinical trials,
development and commercialization of product candidates. You are urged to
consider statements that include the words &#8220;may,&#8221;
&#8220;will,&#8221; &#8220;would,&#8221; &#8220;could,&#8221;
&#8220;should,&#8221; &#8220;believes,&#8221; &#8220;estimates,&#8221;
&#8220;projects,&#8221; &#8220;potential,&#8221; &#8220;expects,&#8221;
&#8220;plans,&#8221; &#8220;anticipates,&#8221; &#8220;intends,&#8221;
&#8220;continues,&#8221; &#8220;forecast,&#8221; &#8220;designed,&#8221;
&#8220;goal,&#8221; or the negative of those words or other comparable words to
be uncertain and forward-looking. For a further list and description of the
risks and uncertainties the Company faces, please refer to our most recent
Annual Report on Form 10-K and other periodic and current filings that have
been filed with the Securities and Exchange Commission and are available at
<U>www.sec.gov</U>. Such forward-looking statements are current only as of the
date they are made, and we assume no obligation to update any forward-looking
statements, whether as a result of new information, future events or otherwise.

<P style="font-size: 10pt" align="justify"><B>Contact for Cyclacel
Pharmaceuticals, Inc.</B>

<P style="font-size: 10pt" align="justify">Investors/Media: <BR>
Corey Sohmer,
(908)&nbsp;517-7330 <BR>
<U>csohmer@cyclacel.com</U>

<P style="font-size: 10pt" align="justify">&#169; Copyright 2011 Cyclacel
Pharmaceuticals, Inc. All Rights Reserved. The Cyclacel logo and Cyclacel&#174;
are trademarks of Cyclacel Pharmaceuticals, Inc. Numoisyn&#174; and
Xclair&#174; are trademarks of Sinclair Pharma plc.

<P style="font-size: 10pt" align="center">

<P style="display: none; font-size: 10pt" align="center">2
</DIV>
</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>4
<FILENAME>c14970p1497001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 c14970p1497001.jpg
M_]C_X``02D9)1@`!``$`8`!@``#__@`?3$5!1"!496-H;F]L;V=I97,@26YC
M+B!6,2XP,0#_VP"$``("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("
M`@("`@,#`@(#`@("`P0#`P,#!`0$`@,$!`0$!`,$!`,!`@("`@("`@("`@,"
M`@(#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#
M`P,#`P,#`__$`:(```$%`0$!`0$!```````````!`@,$!08'"`D*"P$``P$!
M`0$!`0$!`0````````$"`P0%!@<("0H+$``"`0,#`@0#!04$!````7T!`@,`
M!!$%$B$Q008346$'(G$4,H&1H0@C0K'!%5+1\"0S8G*""0H6%Q@9&B4F)R@I
M*C0U-C<X.3I#1$5&1TA)2E-455976%E:8V1E9F=H:6IS='5V=WAY>H.$A8:'
MB(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4U=;7
MV-G:X>+CY.7FY^CIZO'R\_3U]O?X^?H1``(!`@0$`P0'!00$``$"=P`!`@,1
M!`4A,08205$'87$3(C*!"!1"D:&QP0DC,U+P%6)RT0H6)#3A)?$7&!D:)B<H
M*2HU-C<X.3I#1$5&1TA)2E-455976%E:8V1E9F=H:6IS='5V=WAY>H*#A(6&
MAXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&Q\C)RM+3U-76
MU]C9VN+CY.7FY^CIZO+S]/7V]_CY^O_``!$(`'8"AP,!$0`"$0$#$0'_V@`,
M`P$``A$#$0`_`/W\H`*`"@!K,J*S,P1$!9F8A550,EF)X4`<DFFDVTDKM[)"
M;44VVHJ.K;T27=]CD;_Q_P"#-+9H[OQ'IBR)PT=O,;V13D@@QV2RL&!!R,9'
M>O2HY-FE=)TL#5Y7LY1]FOOFXH\C$9_DN%;C5S&BG'=0E[1KRM24W?RMH9T/
MQ3\`S.(T\101D]#<6>IVD?XRW5E&@_%JWEP[G--7>!E;^[.E-_=";?X'/3XJ
MR"<E&.8QB_[U.M37_@4Z<8_B=CI^K:7JL?FZ7J-E?Q@`EK.ZAN`N<$;Q$[%#
MR.&P>:\RMAL1A9<M>A4H2[3A*'W72O\`(]C#XO"XJ/-A<13KQ76G.,[>O*W;
MT=C0K`Z`H`*`"@`H`*`"@`H`*`"@`H`*`"@`H`*`"@`H`*`"@`H`*`"@`H`*
M`"@`H`*`"@`H`*`"@`H`*`"@`H`*`"@`H`*`"@`H`*`"@`H`*`"@`H`*`"@`
MH`*`"@`H`*`"@`H`*`"@`H`*`"@`H`*`"@`H`*`"@`H`*`"@`H`*`"@`H`*`
M"@#B/&OCK2O!=FKW7^DZE<*QL-+B<+-/MX,TSX(MK56X,C`Y((0,P('K95D^
M)S6JXT_W="#7M*K7NQ\HK3FF^D5ZR:1XF=9[A,EHJ57]YB:B?LJ,7:4NG-)_
M8@GO)K7:*;O;Y[9?B/\`%%Y+AF:UT,,QS)*^FZ!;QJ?FQU?4&0?><B8C')4=
M/M4\BX=4::2GB[+1)5<1)O\`"G?HO<OYGYZUQ'Q1*51MT<"F_B;HX6"6_G5<
M>KM-KJTC/E\)^`](S'J_CT75U'N$EKX=TQKM%8;?E6[+21D@D]=N<=N16T<R
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M56*LM7ISQ2M]I;R7T;7PY^C!0`4`%`!0`4`%`!0`4`%`!0`4`%`!0`4`%`!0
M`4`%`!0`4`%`!0`4`%`!0`4`%`!0`4`%`!0`4`%`!0`4`%`!0`4`%`!0`4`%
M`!0`4`%`!0`4`%`!0`4`%`!0`4`%`!0`4`%`!0`4`%`!0`4`%`!0`4`%`!0`
M4`%`!0`4`%`!0!A>)=>M/#.BWVLWG,=G%F.$$*]S<R$);VT>?XI)F5<\X!+'
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MVG?'L8?"[;H?"?P^UWQEY8V-JNK37D=LS8`9TM+",11IO&0',;`,00.*ZJLL
MPC:68YUA\JYM51HQ@Y)=G.H^9NV]DTVCDH4\KUAE/#^*SCET=>O*HH7ZM4Z2
M44K[<SC*SL["ZA;Q643-K_P@GT^U7[U]I%WJUF]N&4_-YQ^T0.1UQ)A1@YHH
M3=226"XFC6J=*=:%&:EK_+[DUV]W74,13C1BWC^$)8>E'>K0J8BFX:;\S]I3
M?>TM-#+LM'5G.N?#76]0DOK)3--HEP$M?$=M"#EW@6`F#6[1>CK&"<'#1G.*
MZ*N)<4L'GN$IQHU?=C7C>6&E+HI<WOT)O[+>E]I(Y:.#5WC>&L;5=:@N:6&G
M:&,A'JXJ+]GB8+[2CK;>#N>F:9H6D:WIUOXIUG08;+QRMOJ-[I_A];D:4OBB
M]TF)[BTO/[&9ED!FFC3S/+"@E2[91A7RV8YIB,MG7RW`8U8C!N-HRE:I.BIK
MWJ4:O516B>MD[*S1]GE.387-:>&S;,<O>$QT9WE"-Z5.LX-.-:5&RY7)ZR2Y
M5-IR:<9')_LY_%#XJ^/=8\66?CW2#;Z=IL4<]I?'19=%^P:B]R(FT,*ZK]H'
MD>9+B3?-%Y'[R1O-7'RA]J?6-`!0`4`%`!0`4`%`!0`4`%`!0`4`%`!0`4`%
M`!0`4`%`!0`4`%`!0`4`%`!0`4`%`!0`4`%`!0`4`%`!0`4`%`!0`4`%`!0`
M4`%`!0`4`%`!0`4`%`!0`4`%`!0`4`%`!0`4`%`!0`4`%`!0`4`%`!0`4`%`
M!0`4`%`!0`4`%`'A7Q/2?Q-XJ\(^!()&2WN';5M3,9Y6`&6,.PS@-':P7I7/
M\4Z>U?7\/N&7Y=F6<2BN>"]C23_FT=O24Y03MTBSX7B=3S+-<HR*G)QIU&Z]
M9KI&\E?R<80J-7ZR0>)K&'Q5XMTOP';G[%X6\)V$&J:ZD+>5%A8E%I9;LX7;
M;F-03RHGF?K&#1@*LLNRW$9O->TS#,:DJ6'<E=ZM\\_G*[[-QBMI,,SH0S3-
ML+D5/]QE64THUL2HNRTBN2GY6@XI/=*<Y;Q,.ZDL/$*CQ3KEK-)X1TZ[&C^`
MO!]DAB.O74;&WBE-N@Y21HR``,".-E/R1E9NNG&M@6\NP=2,<RK0]MF&-F[_
M`%>#7,US/K%/YR::UE>'%5=#'I9ICJ4GE.'J+#Y7E]-<OUF:?*GR+I)K:VD4
MXZJ-JD]Y_:U[-_9VLZSK<-S'$N/`OPULUVZ-;."T,.J:BN(8Y"I`99&[[D^7
M&(I?5J,?;X7"T'3;_P!_S2;O6DOBE2I/WVNSBO*6I=?ZU5E]7QF,Q,*D4K99
MD]-?[/!W<8UZJM"+:W4F^\?=L936K:),GV3Q!\0?`]Y))LMY?%R+?>'KJ8;?
M+AN+VT9X(E8DY:5)%&?:NA5%BH/VF"R[-:45>4<&W3Q,(O>4832F[=HN+9RN
MD\%47L<?FN259.T98]*IA)RZ1E4IWA&^MW.,HKKH:B:7'8R+XDU?1+&R^(FG
MQ:Q=^&_#NDZSI^GQ?$&\TK37NEFL;$%FW2%U60P`!@X>1=IVCR,PS;V%"I@,
M#BGB\%B8+2O"3JX>[UI*<K7M;2ZER;)WU/<RK)/;XFEF>88-8',,)4>N'G%4
M,39:5G"-^6]]>5QY]VK-Q69I'PQN/BEX@\!_&7QI9Z[X&\4Z((Q<>$%ES"YT
M;5+R?29FDN(H[BPCFWB2>W9"9(W\L[,L[_+GV1]/4`%`!0`4`%`!0`4`%`!0
M`4`%`!0`4`%`'#3^.+2#Q`N@&RNC(US;6XG5&\K%Q=K8&5GV;$*7DD:^46WM
M&QF`V(<@'<T`%`!0`4`%`!0`4`%`!0`4`%`!0`4`%`!0`4`%`!0`4`%`!0`4
M`%`!0`4`%`!0`4`%`!0`4`%`!0`4`%`!0`4`%`!0`4`%`!0`4`%`!0`4`%`!
M0`4`%`!0`4`%`!0`4`%`!0`4`%`'C^D1?:_C)XKN)1DZ1H&F6MJ<#""\M[&X
M<GC.[,DX!'9R.]?38F7LN%\NA#3ZSB*LY^?)*I%?+2/S1\AA(^UXQS6I)?[G
MA:,(>7M(4IOYZRVZ-G.J\B^&?BSK<1,=[K'B:[T%).0T<*W-KH\`#G^!?[0E
M/'N.PQW.,?K_``YA&KTL+A88AKHY<LZTM.[]FCSE*4<LXKQT5RUL7C:F%3V:
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M#K]]=VMQ):Z)=,+>RU%;9[<3PW-]-:3VUH`)T8>>OSX(16VL5QIU)TIQJ4IR
MIS@[QE%N,D^Z:LU\CIJ4J=:$J56G&I3FK2A.*E%KLXM-/YHS[+P?9)J2:QK+
M6^OZGINJ:I>>%KV]TO38+GPGINJ6UO:OHFDS6ENC"U2*%E\V0M*XF(=B%7$M
MMMMN[>K;WOW922BE&*48Q5DDK));));)'7TAF!XI\1Z?X0\.:UXFU5F73]#T
MZYU"X"8\R18(RR00@D`SS2[(D!(R\BCO0!X1X6TCXM?$_2K/QAK_`(^O_A[I
M.MPQZCH7A+P?8:;]JM=+N%,MA<:GK>IVLTT]U/`T,IC6,)L<<1LYCB`+/CVR
M^)_@'PAI7BK2O&>J>,;OP5JDNI^(["YT[3;+_A)O!\CQM>VMS!9P;/M^GVZ2
M2)=1>6S1&9W#/&@(!?\`B%\3+G4?#7A#2OAC>)/XL^*GD1^%[M523^Q]',:7
M&L^(KR(AA"MA:%T*N"5F+85F@9*`*/B'Q1XVF\5Z-\&/A_K,:ZWIOAVVU7QK
M\0-=M8=3NM+LF6*"&2WTW"6]SK=Y(Z3;'3RE%U$%54#O$`=AX?\`A[XRT35]
M.U*Y^+OBK7[:&1VU;2-7TS07T_4XWC=%CM_L]G%+I.QVCD!BD<DQ8/RNPH`R
M_A!XDUW7M=^+]KK&I3W\&@?$C5-(T:*81!=/TV%%,5I#Y<:GRESQN+'U/-`'
ML>I:A::1I]]JE_,MM8Z;9W-_>3N<)!:VD+W%Q*WLL4;M^%`'R5\+OB)X_/C7
MPOJ'CC4Y7\*_&:P\1ZAX/TJ:"&./PW=:;J4ESI.G">.,%UN=!,3(6=C(;F#.
M7#$@'L7Q9^(.K>$(_#?AWPG86VI^.?'6IOI'ANWO2XT^S6!(WU'6=1$9#O:6
M44\+LBD9WEB=L;!@#(B^&7Q->(7EY\=/$R:\0KDV/A[PW%X=AD(W/"NB269\
M^$-A59YE8J,L,L:`.2\5W'C;Q#\=X_`&E>/M<\):/'\.(/$<G]C6NFRF348]
M7ELI'9;VVDV++'*F<'@Q(`!DF@#KO$6F>*_AY\+_`(CZG)\0-?\`$VK0>'[_
M`%#2=2U6VTR"XT>>SLIBIM%L[9$;=(5<^8K<QK@=<@';?"K5=0USX;>!]8U:
MZDO=3U+PSI-[?7<H027-U/:1R33.(U50S.23M4#GI0!VK6%D;@736L)N`R2>
M:8UW>9&C1QRGC!F2-F19"-RJQ4$`XH`MT`%`!0`4`%`!0`4`%`!0`4`%`!0`
M4`%`!0`4`%`!0`4`%`!0`4`%`!0`4`%`!0`4`%`!0`4`%`!0`4`%`'B6CZ-J
M'CRP\0>(G\5>(]%UU/$OB?2?#DFE:YJD.B^'H?#.O7VCZ:+GPM:7MKIGB`2R
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M:?Q1J>Q<U&LJCHVE3KQA[24*:K>=+\5=1\%?#CP)K&J6ND:C!<>`=&UB^U3Q
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MV<SK8U/41K7_``J9-2_M<7MR-4_M`^&5N#?C4!+]H^V^?^\\_P`SS-_S;MW-
M=N<J-+%5(P3IP6,PT+4[Q]R6*HQE%*%G:46XM1W3:MJ++DIXB49I22KXQ)2U
M5HU:ZBK/2T4DHK9))+8R]#*MK/A>?P=-\4A$MEJLGC%_&4GQ1_L)]*;0IVMF
MMC\2,P-J_P#PD/\`9;0-I'[X0B\\PBW)SGF#=&EG#A^[PU/"8OV?PQJQQ*J4
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MUH>PJ*%:C4IWC&-6*E%T[5)0FVXN<+.1>N_BGXIT^75UN/`FG2P^'O$_A[PE
MJLECXPGFDEU7Q+;:`]C_`&+#<^$[87]O%=Z_;Q3M=2:>RQA98TE9VABBDO:_
M5/9KE^NU,30I<_N\M;#+$.4ZO+S<F$;H6]O#VE5?O7]6?LXJJZG[E5N9?[MA
MZ>+J*._L)U)1:IWY5*M&G"53V<W3A*7+!5E?F6JWQ%UJ#1_$-U>>'=`T_5/"
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M*?2?$-\EKI]EH5IXNG3[=;V^BZ;'K%M;0Z1-9117<4@E`M]0D*748CCSA.G#
M"X:O.3B_[*K8RK-QNI1IUL/&3Y+\L:DU._-%)TU!P@VJU2VU:G)5<;3I1YJ=
M.OEU*G%>[-RQ,,,U[RO**;JJK./,U*52=!WI4XSGUWA_QCXHUNQBUM?!`&@Z
MIHUWK7AV>R\2V,^K7<(2.?2+/6=+U*RTZ#1KW4[26-XA;W^IPPL'2ZF@`5W=
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M)>ZE"M%SIT^9<W[^=-<ZA)1I)5*'-7C&<Y4O1*184`>8V$*V'Q8UT$;#KGA7
M3K^+OYCV%RNGS8/\)6..'Y??->_6DZO#F#MM@\75IOR52/M%IYMO4^9H0CA^
M*\=IRO&X*E57FZ4U2>O1I16GS,M-,>72_B=X<ACW7<&N2Z_90<XE6_@L]9L%
MC4?-\]Y93QYZ;U;TKH=>,,1D&.E+EI2PZP\Y?RNG*="I?II"<9>C7<Y%A92P
MO$^70C>M#$RQ5./=58T\1226_O5*<HWVYK]CH)ME_=M>6FUT\2Z/HVJ:4SD"
M-]1T"X;44M3TVR2P3P,,G.+>8X_=FN*-Z%-4JEXO`5J]*LENJ>(BJ;GYJ,HR
M6BWE'7WD>A/EKU76HV<<RP^'KT&]G5PLG64.EI2C*+U>T)NWNL[JUN8KN".X
MA)V2+G:PVO&PX>*1.J2HX964\JRD'D5Y%2G*E.4):./;9KHT^J:U3ZIW/=I5
M(U:<:D/ADMMFGUBUTDG=26Z::98J#0*`"@#S#XT>'-2\5_"WQKH&CQ&?4[W2
M&>RME&7N9[&YM]06TB&1F><6AB3_`&Y%S0!2^#WQ!\.^,/`_A\V=_9P:KI>E
M6.DZYHDLL=OJ&E:IIUM':7<$]C*PEBA,L$C1.5PT9'.Y6"@'JD4UI>Q/Y,MO
M=P$R02>4\<\1(^66%]A92><,I]<$4`?*/[/OA+1-(^(7QE>SMY/^*7\1OX7\
M.1SS//'HF@W=W?ZK<:=IR2$BV@DO2KL%Z^6,\LY<`O/JUI\-OVC?$=_XIEBT
MO0/BCX=T.+0=>NE$.GQZQH,%M82Z3=7SL([61UBEDS(57,UH"1Y@-`'TV-1T
M\M`JWUF6N6V6RBZ@+7#$$[8`'S*V%8X7/"GTH`^>_@;<6\'B3X[":>&$GXLZ
MR0))8XR1Y:C(#,#C/>@"3]HS6-2O?"^C?#OPJ@OO$7Q+U0:3:VT-U%;F31-.
M5=1UV7[6^4@@:&."WDD8$".[E.#MQ0!YO\4X/BY>^"M,EC^%&D>&(_AK=:;X
MIT34].\<V>K7&DP^%X"QAATZ+3H'NX381LC1K("1&IPQ4`@&K\1O$EH=<^`7
MQZC2>;P=:"\M==E@5Y?[$B\4Z:MK#=7"1J6$=M/->1S''W[1(QEY%!`/JFU\
M0:#>6$>J6>M:5<Z;)&LT=_!J%I)9M$R[E=;E)3'M*\YW=C0!\G^-?">B>,_V
MFH])UR\U*RLD^$\-]'/I.KS:+<F>+7IHT4W=NZN\)CGD)B!P2%8_<H`[_P`8
M^#-`\$?!/XI:=X?O]4OK>Z\.:W>SOJVM7&MSQS-IGD!8Y[F1FABV0J=@P,EC
MWH`[#X+7=HGPF^',;75LKCPCH:E#/$&#?8HAM*[\AL\8ZYXH`]8H`*`"@`H`
M*`"@`H`*`"@`H`*`"@`H`*`"@`H`*`"@`H`*`"@`H`*`"@`H`*`"@`H`*`"@
M`H`*`"@`H`*`"@#S?4?AGIU[<:O]GU_Q/I&C>([DWGB3PSI5YIL6BZW<3;5U
M"262ZTBXU/2QJ$*)%=KI.HZ<LPWN0)9I9)9IPA"G&A.*KX>G.52%*HKP@YS]
MJXZ<LIT?;7K>PJ2G0<IU(2INC4G2E4I2YW5A)T:\HPBZL-)M4X*E"23O"-2%
M-1A&M",:J482Y^>G3E&I!X-BNOB9!XJ;1+C2;'PQX:30-*9[FP6QU:ZD>7[)
MJ%CIVG7LS00Z7IEYJUC&]]%:R_\`$ZN%BB\I1))I1G.+S&O.3]KCG3ARR;E-
M<M2<L55EO!?6W3R]QE&<JLHX5QK1I<L54RJPCR8#"PBE1P+J5$TK1O.G2IT:
M4;^\U02KNHI0C!5)TI49S_>6U;?P!;6>I375GXC\4VFD3:I?:VWA2UOM/M]`
M&J:FL[WT_F0Z4NK26TU]<W-Z]A+JDEDUQ,S&VV!8UQ=*+PTL+-N=-4:N'IN6
M]*E54HVBDE&?LX3E3H.O&K[&')[/EE2HRIZN3]JJT?<J.=.=1QT]K*DH*#FW
M=PTI4E/V+I>U4&JG.JM=5><N/@MX?ELETV'7?%-C82>"M,\!:G;VEUHJMK&A
M:/#>Q:>+R[FT*6ZM+E&OYI'.FSV$4[!5GBEC!1MJLI5*F)J.3@\3B*>*:A[J
MAB:*BJ-:+^-NDX0E"G4E.BI*5Z;C5K*H0E[.5&<4E.A+$.,O[F*K>VK4FK\J
MC*5XJ<5&O&+]VLI0IRAOGX>0I?O>6GBKQ?IL=ZVD3:]8:;?:59V_B.]T>"VM
M(]1U&YCT7[?87ES9V5G;W1T>]TN.>.V16C&6WM3Y:DI\J]G[>IB(47?V5*I5
M?-)02:E*E[3][["K.I1E4<W.$XU:L9XJFHT:5&+<94J,,/[73VDJ,.91C)VY
M%)*=1*K3A"M#GO"I%TZ#I3V?@*UL-4GO+3Q!XGM]*FU#4M67PK!?64'AZ'5-
M82;^T;L"#34U&XCFN;J\NS8W6HW%BMS=-,EJK)%Y6#I1>&GA9MSIO#U,-!RL
MW2I5)7M!6492IQO2HRJQJ2HTOW=-Q48\N[F_:JJDH3YZ=2HXZ.K.E&,8.;=W
M'W84U-4G257D3J\[G5=2TW@C2F\!_P#"O#<:@-%_X1D>%?M0EMAJG]G#3QIH
MF\[[)Y'VWR!NW_9MF_GR\?+6V*D\75=6I[LG5IUK1T7-3JQJQ6MWRN4$FKW<
M;V:>J5"3PTW.&K<ZL[2VO6E.4MK:)S?+U2M=O6_4):QI:+9`OY26RVH8E?,\
MM8A$"2%QOVCKMQGMVJ,5%8N.)C4]U8E5%+ETM[2ZERWO:UW:][=;F>'BL+&A
M&GJL.H*/-K?V:27-:W97M;RL>>S_``J\.7.C:;H4]SK#6.E^`]4^'D)%U;1S
MRZ)JT6CPW-S/)%9+G4U71;0I(BQPYDEWP.K`)>(D\14Q=2:498N>&J2LDU&>
M$JU:U)QC-3BUSU7SQJ*I":48N/+S*6E*3I.ERK2EB*V(2=U>6(C5A4BVFFH<
MM::BX.-2+Y91J*2N5HOA/I@NGOKWQ)XJU2ZE'A03R7DWA^"*8>"]?7Q!X?5;
M/2_#UI:V:03>;;,EI#;K)!<2EP;EA<"HU90JNM\525>6)DY.4G*M4PU;"5)N
M\M/:4:L5-1Y8N5"C-)2=9UL?9Q]BJ";C2CAZV%@E9<E&M[%N*TUE"5+FA.?-
M/]Y.,W.$:4:6]<^`M'NO[8\RYU)?[;\6Z!XSN]DUJOEZIX<_X1_[%!;[K,[+
M!_\`A&['S4?S)&\V?9*FY/*BD_9?5.7_`)@IXF<+]7BOK/M.:UKJ/UJIR6Y;
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MX4$\EY-X?@BF'@O7U\0>'U6STOP]:6MFD$WFVS):0VZR07$I<&Y87`VC5E"J
MZWQ5)5Y8F3DY2<JU3#5L)4F[RT]I1JQ4U'EBY4*,TE)UG6P]G'V*H)N-*.'K
M86"5ER4:WL6XK364)4N:$Y\T_P!Y.,W.$:4:6Q'X"M_[>M-:O/$?B?58-,U6
M_P!;T?0M4NM+N]*TC5-1MKRSEN+.Y.D+J\D4=MJ-]'!:W6J7%M`MSMBA58(!
M!E1_<IV?-45&IAXU)6]I"E5J0J22:24Y6IQI^TJJI4E334Y2E)R>E7]YS+^'
M3G.E4G".D)2HI<CL[N"YXJJXTG3BZEW;EE*+Z;2[34(]'M[/6;W[?J'V9HKV
M\18(_->3?DKY%I;1$JC!-Z6T`<IO\I-VP16I1K8?V$[QY\/"E5E'1RG[&-.M
M4BG=1]I4YZD8ZJ',HI-(J,G3K3J1MRQKU9THO[-+VTI4(2ZMPI<D).[;:;YI
M-\SX:T^$WARRT+5/#\5[K1LM6\$:5X!N)9+FQ-TFCZ/'K$=M<P.NFK&NI,NM
MW?F2-&\1,<6V%=K>9T3JRE)2:2:Q5#&:7_BX>&%A"._P-82GS+XFY3M*-XJ)
M3DZ56E5C\5'ZU9/;_:ZKK5+VL_=D[0LU:.DN9ZFE<^`;>35KK4['Q'XIT.#4
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M7&A^-+=&8^&KJ1-52-=SR>']25;?47"CEFMCY5R`.@CD->WE$E7AB\JFU%8Z
M"=%O1+$4O>IKR]IK!^;2/G\[A+"U,#G-.+;RV;5=):O"UER579;NGI42Z6DR
MUK9_LS4+#QK8@W%B+);#7UMP9/.T.5_M-IJT*H"96L)W:5MH)-M<W!'*`'/"
M+V]&ME-7]W5YW4P_-IRUTN6=%WMR^VBE%7LE5C"^[-,;_LN(H9U07M*'LU2Q
M2AKS8:3YZ=>*7Q.A)N3M=NC.I;9)Q2V]II<125M_A6]N!JFF:I:,K'PY?3N;
M@.LD08)I<LTC30W"AHXC/)#,/L\BXJ,ZE>2<5RYA1C[*K2FK?6:<5RV:=KU8
MI*,X.TI\L9P_>19$Z='"0<9.^55I>VHUZ;O]3JR?/=.-TJ$I-SIU%>$'*5.I
M^ZDK:D:WD)\YXYG:55/]K:&89(+U2N$N+K3)2X2;8`=T2W`/&'`P@YVZ4ERQ
M<8J+?[FOS*5/76,*L;-QOTDX><;W;ZHJM#WW&3<DOW^&Y7&HK:3G1E=*5NL%
M46UI6M%/EDEN246VUK4!GY8)XHM)L\C'%Q(\<$DL6><;9@<$;6!P5&,:>O/0
MH?WHMU9_]NI.<4_.\6NZ'*4JCY53Q.(72,HQH4_^WVU3E*/6UII_RO8T+74%
M%PNFW5Q;2:H4>>6VL8YGBLX./+$\ASY0((57F\HRDDH@`(7"I0:@Z]*$H8=-
M1C*HTG.77E6E^[4>907Q2;U?32Q"518:K4A+%6<I0I*3C3CTYGKR]DY\CF_A
MBE=+7KF.L*`/,?$OP9^%_B^^DU/7_!FDW>HS/YD]_`+G3+RXD/5[FYTNXMI+
MESGEI6<GH<T`=AX;\+Z!X/TJ+0_#.EVVCZ5!))+'96@<1K+,0TLI,CL[R.P!
M9F8D]S0!'HOA/P]X=O\`7M3T;34L;[Q/?C5-=G2:ZE-_?@.!<.D\[I"<22?+
M"L:_,?EH`LZ[X=T+Q/I[Z5XBTC3]:TZ1E=K/4K6&[@$BYV2HDRGRY5R<.FUA
MDX/-`'"^'O@E\+/"FKP:]H'@ZPT_5K1WDM+P7&I7+6CRH\;M:Q7E[+%;$I)(
M/W:+@.<=:`,W5_V??@_KNJ:AK6K>#+>[U/5+R>_O[HZMK\!N+NZD::>9HK?5
MHXT+R.S81%49X`%`'6:/\-?!&@7F@WVDZ%%:77A?2KK1=`E-YJ-Q_9>FWT\U
MQ=P6\=U>2)OEEN9MTSJTI5]F_8`H`.TFABN(9;>>-)8)XI(9HI`&22*52DD;
MJ>&1D8@CN#0!SN@^#/#/AGP\GA/1](@M_#D8ND71[A[C4;3R[V62>[A9=2FN
M"\$LTTK-&S%,R-Q@T`<"_P"SW\&&O/MQ\`:.LNX/Y22:A'8[AT)TR.]6S(Y/
M'D8P2.AH`U_%OP;^&GCK4XM8\5>%X-5U*&R@T^*Y;4-7LREG;O-)#`([#4((
M]JO/*02F[Y^20!@`ET3X0?#GPWHGB#PYHOAJ*QT7Q1"+?7K$:AJ\RZA"L4T`
M1IKG4))8/W4\JY@DB/SYSD`@`Y>#]FWX*6T\-Q!X&MXYK>6.>%QK/B0[)8G$
MD;!6U@J<.H.""/44`>XT`%`!0`4`%`!0`4`%`!0`4`%`!0`4`%`!0`4`%`!0
M`4`%`!0`4`%`!0`4`%`!0`4`%`!0`4`%`!0`4`%`!0`4`%`!0`4`%`!0`4`%
M`!0`4`%`!0`4`%`!0`4`%`!0`4`%`!0`4`%`!0`R2..6-XI462*1&CDC=0R/
M&ZE71U88964D$'@@TXR<9*46XRBTTUHTUJFGT:>PI1C*,H2BI1DFFFKIIJS3
M3T::T:/.K"=O`4Z:+J;NWA*YFV:!JTN6317G<XT/5I3_`*JU\QL6ER_R[2(9
M&!537N5H+-X/%8>*CF5.-\116CK**_CT5UG97K4UK?WXIW9\[0F\BFL'B9-Y
M34E;"UY:K#N3_P!VKR^S"[M1J2TM[DGHK:ZZ3J.@.\GAQ8;W1YF>67PW/*MN
MEN\S;Y)-"O&4I;1NS,YLIOW&68QO`&(/,\30Q:4<:Y4<3!)+$Q3;DHZ)8B"L
MY-;*K#]Y:W-&I:ZZUA,1@'*67*-;!SO*6#E)14')W;PU1WC",KMNC/\`=W;<
M)4[M/.2[\-P/CS=7\'7+LY>UE6XTNVWGEW6.1)M+E]?,A+#YN6YK=TL<UI&C
MF=.*5IQY:LK=%=..(7^&=GIHCF57+8.W/B,GJ2;O"2G0A?JTFIX5]^:%UKJ]
M1TVH>&^!=>,[Z_1V5?LUGJ,+,_4"/R_#]I'<$/TP&^;IU-*%#'?\NLJIT''7
MFG3:2\[XB<H*V][:#GB,M_Y>YS5KQ;MR4ZL6WY6PE.-37:U]2Q:37TL/V+PM
MH?\`85BS$R:QK%H;7EL!Y[72&9;N^NF7#"2\^S+G!8R8*F*L*,9>US#%_6ZJ
M6E&C/FVVC*LDZ=.">CC2YWVY=S2C.O*'L,JP/U&@W>6(Q$.3?>4,.[5:DVM5
M*M[-7WYMCI8KBUTXZ=I5SJ7GW]Q&Z6WVN2$7U^;>)I;B?RHD0'"*S,4C5%X'
M&0#P2A4K>WQ%.AR4:;3ER*7LZ?,[1C=MO5NRNVWOKJ>G"I2PWU?"U<3SUZB:
MASN/M:KA%RG+EBHK1)MM145MIH:=<YTA0`4`%`!0`4`%`!0`4`%`!0`4`%`!
M0`4`%`!0`4`%`!0`4`%`!0`4`%`!0`4`%`!0`4`%`!0`4`%`!0`4`%`!0`4`
M%`!0`4`%`!0`4`%`!0`4`%`!0`4`%`!0`4`%`!0`4`%`!0`4`%`!0`4`%`!0
M`4`%`!0`4`%`!0`4`%`!0`4`0W%O!=02VUU#%<6\R-'-!/&LL,L;##))&X*N
MA'4$$54)SI3C.G)TYP=XRBVG%K9IK5/T(J4Z=6$J56$:E.::E&23BT]TT]&G
MV9QB>'M9\/\`_(J:C$^G+DKX<UQIY;*`9)\O2]3CWW.G)V6*1;J)<_*J"O5>
M-PN,_P"1C0<:W_03AU&,Y>=6D[4ZC[RBZ<WU<F>,LNQN7_\`(IQ$98=;8/$N
M4J<?*A6C>K17:$E5@NBBBT/$FIVZE=4\(:[`X!R=-^PZU:N,D'RWMKI9B,<X
M>VC8YZ9K/ZAAY-/#9GAY1Z*K[2A->JE!P^:FUYFBS+$TTUBLGQ-.2_Y\^RQ$
M'Z.$U/Y2IQ?D,7Q9&-PM?"_BR23:6"#09+(,1]U?-OI+>,$Y[OQ3_LV6GM,P
MP<8WW^L*=O\`MVFIR_`2S:*O[+*\?*5KV^JNE?RYJKIQ_$C:Y\;ZJ?+M=.L/
M"MJ>&O=2GBUC5`A)^:WTZQ?[)%)MQS-=2@$\H<8JE3RG"J]2O4S"HMH4HNA2
MOVE4J+VC5_Y*<6_YD2ZF=XM\M+#4LJI=:E:<<17MWA1I/V47;^>K)+K%FMHW
MANPT:2:[#W&H:M=*%O-8U&07&H7"@Y$0DVJEK:AN5M[=(HEX^7/-<V*QU;$Q
MA2M&AAJ?P4*2Y*<;];:N4WUG-RF^]M#KP>6T,%*=6\\1BZJM4Q%9\]6:WY;V
M2A!/:G348+M?4Z"N(]`*`"@`H`*`"@`H`*`"@`H`*`"@`H`*`"@`H`*`"@`H
M`*`"@`H`*`"@`H`*`"@`H`*`"@`H`*`"@`H`*`"@`H`*`"@`H`*`"@`H`*`"
M@`H`*`"@`H`*`"@`H`*`"@`H`*`"@`H`*`"@`H`*`"@`H`*`"@`H`*`"@`H`
M*`"@`H`*`"@`H`*`"@`H`*`"@`H`*`"@`H`*`"@`H`*`"@`H`*`"@`H`*`"@
M`H`*`"@`H`*`"@`H`*`"@`H`*`"@`H`*`"@`H`*`"@`H`*`"@`H`*`"@`H`*
M`"@`H`*`"@`H`*`"@`H`*`"@`H`*`"@`H`*`"@`H`*`"@`H`*`"@`H`*`"@`
MH`*`"@`H`*`"@`H`*`"@`H`*`"@`H`*`"@`H`*`"@`H`*`"@`H`*`"@`H`*`
M"@`H`*`(9YX;2":YN)4@M[:*2>>:1@D<,,2&2661CPJ*BLQ)Z`&@#E]$\>>#
M_$=V;#1-?L;Z\\IITMXVDCDFA0X>6V6>-/M,:GJT6\#!R>*`.NH`*`.*A^(O
M@B?4QH\/B736U`W36*P^8ZHUZC%&M$N6C$#W.\%?*$A;/&*`.UH`*`./U+Q_
MX-T?5CH6I:_96FKJ]M&;"3SC.'O`C6P(2)@/,$L9'/\`$,T`=A0`4`<O>>-?
M"FGZU!X<N]<L8=;N7ACBTXN[3^9<$"".3RT987D)&U9&0MD$#F@#J*`"@#E[
MGQKX4LM;A\-W&N6,>N3O#%%IN]FG\VXQY$3^6C+#))D;4D92V1@<T`=10`4`
M%`!0!6O+NUT^UN+V]GCM;.TADN+FXF81Q001*7DED<\*BH"2?:@#G-#\<^$O
M$ERUEH>NV5]=K$9Q;(9(II(`<&>".XCC,\()Y>(.OO0!UE`!0!Q^E^/_``;K
M.J?V)I6OV5[JFZX3[%!YQE#V@<W"Y,04&,1OGYOX:`.PH`.GX?TH`R-%UW1_
M$-F=0T2_@U&R6>:U-Q;EC&+B`A9HOF53N4D9X[T`:]`$4\\5K!-<SNL4%O%)
M/-(WW8XHD,DCMC^%44D_2@#F=`\<>$_%%Q+:^'];L]4N+>'[1+%;>=E(-ZQ^
M82\2C;O91P3R:`.KH`*`,32O$>AZU<:G9Z3J=K?7.C7/V/4X;=RSV5SND7RI
M00/FW12#*Y&4//%`&W0`4`<O#XU\*3ZZWAF#7+&;78W>-].B=I)4EBC:62%G
M1#&LR1JS-&7W`*<CB@#J*`"@#C[7Q_X-O-9/AZUU^RGUE;J>R.GQ^<9ENK7S
M!/`3Y6P.ABDS\W\)H`["@`H`*`"@`H`*`"@`H`*`"@`H`*`"@`H`*`"@`H`*
M`"@`H`*`"@`H`*`"@`H`*`"@`H`*`"@`H`*`"@`H`*`"@`H`*`"@`H`*`"@#
MF_&/_(H^*/\`L7=:_P#3=<T`>$_"_P`):]KEG\,?$E_)I5CHOA/2K\Z4ED]Q
M+JVIO?F:$B_9XDBMH$()\M&DSD_WSM`/IJ@`H`^'-(D.HQP^$M46+2_#>M_%
MK6+AO$BDRSP:KI\T<MOI"1X5+*2Z)B5;II&QYC?)\I-`'W'0`4`?-(DOXOCQ
MXK^PZCH&GI_9?AL7HUV)I#=6GE:=OM],*W,7E7[<[6/F`9'RF@#Z6H`*`/F3
M7;^;X<_$235M(U+1=?L/'/B/3K+6O#KO%+X@TS40H19[0Q.SQQ1K)N"NH`+H
MA7[K@`^FZ`"@#YDU6^G^'/Q'>^TG4M%\0Z;X]\3VEKJ^@%HI?$&DZF0L9GMV
MB=G2*+S"0L@`&Y4*@[7H`^FZ`"@`H`*`.*^)'_(@>,O3_A&]7_\`2*:@#P;X
M9N=:\5^!+?65CT:Y\(^!8+KPW#"3(_B:RU2U\F>[:Z8((X[9<@VBJY#B1M^%
M-`'U=0`4`?-/P+DOQ/X@1=1\/IIC>*O$>[3'B/\`PD;W8,!%Q!,+@`6(0<IY
M+'*2'<.:`/I:@!K?=;Z'^5`'A/[/MW:?\(7-9BYM_M8\0:Y*;431?:1$9H1Y
MA@#;Q'D_>VXYH`]XH`Q?$?\`R+VO?]@75/\`TAGH`\=^`$E__P`(?ID<^HZ!
M-8BSN38Z?9Q%==LS_:MYY[:K*;AA)&SG,>(H\*Z9)H`]\H`Y_P`5ZY%X9\-Z
MWKLI`72]-N;I0>`TRQD6\?U>X:)/^!4`?,OPNN6\+>-?#-O<6.L:</&WAB2+
M59=7L9+**_\`$\%S<:K]ILGD8BYC:"X\H.,9WKQ\U`'UU0`4`?,GAZ^F^'_Q
M#M?"VG:EHOBCP]XUUO5]0C%JT,VO>'[]O^/IKR:!GW0JPV'S.JQ2D;&5@P!]
M-T`%`'S1\)I+]?&?CU(]1T"#36\<ZZ+G3[N(G7;J<M=>2^FS?:%5(%;874Q2
M$A'P1F@#Z7H`*`"@`H`*`"@`H`*`"@`H`*`"@`H`*`"@`H`*`"@`H`*`"@`H
M`*`"@`H`*`"@`H`*`"@`H`*`"@`H`*`"@`H`*`"@`H`*`"@`H`BG@AN8)K:X
MBCFMYXI()X)5#Q2PRH4DBD1AAD9&92",$$B@"&QL;+3+2"PTZU@L;*U3R[>T
MM8D@MX(\EMD448"HNYB<`#J:`+=`!0!SS>$_##6<FGMH&D-8S7YU26T-A;&!
M]28Y-^T?E[3=D_\`+7&[GK0!T````'``P!Z`=*`%H`YN^\'>%-3O_P"U=1\.
M:->ZEOAD^WW6G6T]WOMP@MV\^2,ONC"(%.>-HQTH`Z2@`H`P$\*^&H]7?7TT
M#2%UJ1B[ZJNGVPOF<C:9#<^7O\TKP7SN(X)Q0!OT`%`&!'X5\-0ZM)KT6@Z1
M'K4C,\FJ)I]LM\SL,-(;D1[_`#6'!?.XC@GF@#?H`*`"@`H`KW5K;7MM/9WD
M$5S:7,3P7%M.BR0SPRJ5DBEC<%71E)!4C!!H`S4\.:!%-ID\6C:;'/HD)MM(
MF2S@273;=EV-!92*@:WA*D@HA"X)XYH`VJ`"@#F['P=X4TO4!JVG>'=&LM3!
MF87]KIUK!=@W`83D3QQA\R!WW<\[CGK0!TE`!0!SNF>$?"VB7C7^D>'M'TR^
M>.2)[NQT^VMKAHI65Y(VEBC5BC.JDC."5![4`=%0!'+%'/%)!-&DL,T;Q2Q2
M*&22.12CQNIX9&4D$'J#0!AZ1X3\,Z!/+<Z)H&DZ3<31>1+/I]A;VDLD.X.(
MG>&-2T>]5.TG&0#VH`Z"@"EJ&FV&JVDEAJ=G;7]E,4,MI=PI/;R&.198]\4@
M*MMD1&&1P5![4`17>CZ5?2V$UYIUG<S:5,+C3)9[>*22PG`51+:.RDV[X11E
M"#A1Z4`:5`!0!@:?X5\-:3?W&J:9H&D6&HW1<W%[::?;074AE.Z4M-'&&^=B
M2V"-QY.30!OT`%`'-P^#O"EMJ?\`;4'AS1H-7$\MU_:4>G6J7OVB??YT_P!I
M6,/YK^8^YLY.\YZT`=)0`4`%`!0`4`%`!0`4`%`!0`4`%`!0`4`%`!0`4`%`
M!0`4`%`!0`4`%`!0`4`4M1AO9[.:'3KR/3[U@H@NY;47L<)#J6+6K2Q"7<@9
M<;UP6SVP0#E/[&\<_P#0ZZ?_`.$G#_\`+>@`_L;QS_T.NG_^$G#_`/+>@`_L
M;QS_`-#KI_\`X2</_P`MZ`#^QO'/_0ZZ?_X2</\`\MZ`#^QO'/\`T.NG_P#A
M)P__`"WH`/[&\<_]#KI__A)P_P#RWH`/[&\<_P#0ZZ?_`.$G#_\`+>@`_L;Q
MS_T.NG_^$G#_`/+>@`_L;QS_`-#KI_\`X2</_P`MZ`#^QO'/_0ZZ?_X2</\`
M\MZ`#^QO'/\`T.NG_P#A)P__`"WH`/[&\<_]#KI__A)P_P#RWH`/[&\<_P#0
MZZ?_`.$G#_\`+>@`_L;QS_T.NG_^$G#_`/+>@`_L;QS_`-#KI_\`X2</_P`M
MZ`#^QO'/_0ZZ?_X2</\`\MZ`#^QO'/\`T.NG_P#A)P__`"WH`/[&\<_]#KI_
M_A)P_P#RWH`/[&\<_P#0ZZ?_`.$G#_\`+>@`_L;QS_T.NG_^$G#_`/+>@`_L
M;QS_`-#KI_\`X2</_P`MZ`#^QO'/_0ZZ?_X2</\`\MZ`#^QO'/\`T.NG_P#A
M)P__`"WH`/[&\<_]#KI__A)P_P#RWH`/[&\<_P#0ZZ?_`.$G#_\`+>@`_L;Q
MS_T.NG_^$G#_`/+>@`_L;QS_`-#KI_\`X2</_P`MZ`#^QO'/_0ZZ?_X2</\`
M\MZ`#^QO'/\`T.NG_P#A)P__`"WH`/[&\<_]#KI__A)P_P#RWH`/[&\<_P#0
MZZ?_`.$G#_\`+>@`_L;QS_T.NG_^$G#_`/+>@`_L;QS_`-#KI_\`X2</_P`M
MZ`#^QO'/_0ZZ?_X2</\`\MZ`#^QO'/\`T.NG_P#A)P__`"WH`/[&\<_]#KI_
M_A)P_P#RWH`/[&\<_P#0ZZ?_`.$G#_\`+>@`_L;QS_T.NG_^$G#_`/+>@`_L
M;QS_`-#KI_\`X2</_P`MZ`#^QO'/_0ZZ?_X2</\`\MZ`#^QO'/\`T.NG_P#A
M)P__`"WH`/[&\<_]#KI__A)P_P#RWH`/[&\<_P#0ZZ?_`.$G#_\`+>@`_L;Q
MS_T.NG_^$G#_`/+>@`_L;QS_`-#KI_\`X2</_P`MZ`#^QO'/_0ZZ?_X2</\`
M\MZ`#^QO'/\`T.NG_P#A)P__`"WH`/[&\<_]#KI__A)P_P#RWH`/[&\<_P#0
MZZ?_`.$G#_\`+>@`_L;QS_T.NG_^$G#_`/+>@`_L;QS_`-#KI_\`X2</_P`M
MZ`#^QO'/_0ZZ?_X2</\`\MZ`#^QO'/\`T.NG_P#A)P__`"WH`/[&\<_]#KI_
M_A)P_P#RWH`/[&\<_P#0ZZ?_`.$G#_\`+>@`_L;QS_T.NG_^$G#_`/+>@`_L
M;QS_`-#KI_\`X2</_P`MZ`#^QO'/_0ZZ?_X2</\`\MZ`#^QO'/\`T.NG_P#A
M)P__`"WH`/[&\<_]#KI__A)P_P#RWH`/[&\<_P#0ZZ?_`.$G#_\`+>@`_L;Q
MS_T.NG_^$G#_`/+>@`_L;QS_`-#KI_\`X2</_P`MZ`#^QO'/_0ZZ?_X2</\`
M\MZ`#^QO'/\`T.NG_P#A)P__`"WH`/[&\<_]#KI__A)P_P#RWH`/[&\<_P#0
MZZ?_`.$G#_\`+>@`_L;QS_T.NG_^$G#_`/+>@`_L;QS_`-#KI_\`X2</_P`M
MZ`#^QO'/_0ZZ?_X2</\`\MZ`+%II7C&*ZMY+OQ;8W5K'-&]Q:IX9BMGGA#`R
M1+<#4W,+,N0'"-C.<&@#L*`"@`H`*`"@`H`*`"@`H`*`"@`H`*`"@`H`*`"@
M`H`*`"@`H`*`"@`H`*`"@`H`*`"@`H`*`"@`H`*`"@`H`*`"@`H`*`"@`H`*
M`"@`H`*`"@`H`*`"@`H`*`"@`H`*`"@`H`*`"@`H`*`"@`H`*`"@`H`*`"@`
@H`*`"@`H`*`"@`H`*`"@`H`*`"@`H`*`"@`H`*`/_]D_
`
end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>5
<FILENAME>c14970p1497002.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 c14970p1497002.jpg
M_]C_X``02D9)1@`!``$`8`!@``#__@`?3$5!1"!496-H;F]L;V=I97,@26YC
M+B!6,2XP,0#_VP"$``("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("
M`@("`@,#`@(#`@("`P0#`P,#!`0$`@,$!`0$!`,$!`,!`@("`@("`@("`@,"
M`@(#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#
M`P,#`P,#`__$`:(```$%`0$!`0$!```````````!`@,$!08'"`D*"P$``P$!
M`0$!`0$!`0````````$"`P0%!@<("0H+$``"`0,#`@0#!04$!````7T!`@,`
M!!$%$B$Q008346$'(G$4,H&1H0@C0K'!%5+1\"0S8G*""0H6%Q@9&B4F)R@I
M*C0U-C<X.3I#1$5&1TA)2E-455976%E:8V1E9F=H:6IS='5V=WAY>H.$A8:'
MB(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4U=;7
MV-G:X>+CY.7FY^CIZO'R\_3U]O?X^?H1``(!`@0$`P0'!00$``$"=P`!`@,1
M!`4A,08205$'87$3(C*!"!1"D:&QP0DC,U+P%6)RT0H6)#3A)?$7&!D:)B<H
M*2HU-C<X.3I#1$5&1TA)2E-455976%E:8V1E9F=H:6IS='5V=WAY>H*#A(6&
MAXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&Q\C)RM+3U-76
MU]C9VN+CY.7FY^CIZO+S]/7V]_CY^O_``!$(`"H"-@,!$0`"$0$#$0'_V@`,
M`P$``A$#$0`_`/W'\;>*KGPI:Z3+:VVB3RZKJ_\`9?F^(O$,GA?1[)!I6J:H
M]S=ZK'HVIF/(TWR4C^S89[E`77'*CS2K1HP2O*#EJVFY>VP]"G3A%1?/4J5<
M3",(W3;T7-)I.K1C2K59-QC0BI.R35N9*4I-M<D(0<ISGJDHNZ2O)<_X;\=^
M(]5\7R^%]3\-:!:6L%EJLTFN:'XNU#7;3^T=&N-)M]0TB.&^\&:09[FW;6;+
MSI8Y'AC=I(-[7-O<0V]T5&K1K5DW&-/DY-$_:\]6M2YH^][M.,\-B(.37,YT
MTHP=.:J**BE2E3C97E**FKV=-3IRJT[JS7-.,5)0;4E3G&J[1G2]IZK4C.>\
M0W_B"P@MO^$=T&RUNZEFD%P=3UU?#VFV%K%;RS-/<WD>FZC<O))(D<,<<%A,
M"TNZ5X8T+G*K4=&,YN*]E2IU*DY.2C\'+:$%:SG)2<DYRITHPIS<JBG[.%2X
M13M&[YI2C&*4;ZRNW*6J:@K<KY%4J.<Z:C3<'4J4_/H?BI=75G:ZQ:>&0-"M
M=#\-:[XHNK[61:W^C6_B7>\4>F:?!I=S'K9L[5&NKB22[TZ/R'0P-/(6BCZO
M9)8ETN9JD\73P-.7*U4>)JPP\X1JT7;V4+XS"4ZC]I.=.<ZR=-JCS5,93<*4
MFTO;4:.(Q-6*E>G&CAIUX3E3JI?O75>%Q3H)0C&<:=-U)4E63CN:%XZO-5U6
MR@NM#@T_1-=N-=M/#.J)J[7=]?S^'YYH[A=3TG^RH8])%U;VE[=6WE7U\S16
MS>>MO*?+K*A^\IQD_<J5,+2QT(K6+PM5T.5RF^5QK)8O"N5)1E%.I44:LO97
MG56U*<HQ]ZG#$RP<I?"_K$(5I348ZWI0EAL33=1RC)RA"4:<H5.:#[?Q=XAU
M"\:XT?PE#?\`A:WUVZT&YU,Z^MOKQET_4I='U+5+'PZVDM;76CVU_#,&>36+
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MC;ZM=QV%AHD_B22\O?#_`(CTRWN-!M=GVK5-+EU'2(%UFTA,L0E;3S<^6TT:
MN`TBAM)KV<9RG:G&G.A"7,TG%XJ4XX>33L_9UG"3IUK>RE%<ZGR-2:2;G"E%
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M;F39`80L@D*R(6RNN6$HIM5(UI02BW*4:&(EA:EHI.5_K,?80C;FJU94X4E-
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M7O*I5]G2;6D::J2]G4J4U"K4I[%_X_\`#MKI$NJ6^H02+]F\2S6@NH=6M+:9
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M_!EUXTTVQO\`Q#9Q:;<ZC:VFG0M;S31VEK<7=Q]M>^6)='CMXK6X^T&\$<D3
MPM;K%)>/%:S-IQJX>EI;$3HQC-2C*ERUY05.JIP<HU*<U4A*G*ES^TC*,X7A
M>:TP\%7FH)N%IN#3BU-353V3IJG+EE[15/<E&7(H-2E5E3IPG../K?Q$_LSQ
MAIGA"U'@Z.ZOM/TF_;_A)?&Z^&M0N/[7O[VRAL_#^DIH&H2Z[>J+"5S&)+4%
MIH$W`R[E=&+J8BO27\/#S4)<GOUKJ#JU9*CI:%.DX34I5(J;E**LJ<Y'/[3_
M`&/#8JW*\3"4U&3Y:<;*ER*56W_+R=645RTW;V<FU=QB\Z?XJ36-O/JM_P"'
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M%WDI24XPG'D<J5.O%7NU3J3K4DIV5HU%4P]5.,93CR\DE-N3C#S[5/C`NE^+
M=0\-M;>#\:?XDT/PZ+*X\?16/C747UN/1&CO=(\'S>'MEY;QOK2CYM6A#+97
M#;EV8I85?6/8_P#3Z=>%J?[QTO8U:U+GK+W'"'[GVM3EYYPHR4H0JRM"5XC]
MQ&I+94J"KMS_`'<91Y'4E&G+WN>IRQ<::?*IU7&#E!-S7;W'Q$\(6=QJEO<Z
MG-;C1[?4[F\O)=(UJ/263103K$5AK3:<-/U:\L2LJW-K8W-S/`UO.LD:M;RB
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M&I4Y(2G[J=]"_9^)=&U$8TR\6]<Z)9>(8UBCN`ATK4Q<'3;EYFA"0FY^RW&R
M-R)<0NVS"DTL6YX.GCIRI^]E_-&I&Z2]I&$YNFIJ\9248ISY.?V<:E&<THUJ
M+J.CRU98:*?*L5?DNFFHJ4(R<H.TH6<TDIJ+E*,XJ[IU%#@]$^,7A/Q!_P`(
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MTW3EAGAG4I5HSY94*BIXF%24*RA-7IPY'.M33R3_`':E%<TV\/RPA[_.L3.K
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M/^$EN[VU\[S_`"_L7V/1;[6/,\OR6^T;_L7D[=T6/-WY.W:UQC^_K4+V]CAZ
MM>_?V>)P>'Y+=+_6^?FN[>SY;/FYH\L*O-A<+B>7E^LU:5/EO\/M<-B<1S7M
MKR_5^2UE?GYKKEY95?$WB#4-(ET;3M%TJUU?6M=O+FVLK74-4DT3388;*QGO
M[V[O=2@TO498D2*%8T2&RN'>6XC!"1B26+-.3JNE3BFX4:F(G=\MJ5.I0HOD
MT:E4E6Q-&*C)PCR.<W-."C/9\L*;J2;5ZE.C"*5W*I452=G=I1C&C1K5)2U_
MAJ$8N4XHXZY^('B9K3PYJ&C>%-"OK3Q%?V>CPVE[XNU'3]<@UC[3<6^N6O\`
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M15AGN4672@_AO4O$`9O*B=+T?\2[R`4:)6$XE#8&QNF=)0Q5;#*3M1P]2NI.
M+A*T*N%I*$Z;UISMB;SBVW3G3E3]Z_,LE)JBZDDE*%94)1C+FCS<]2$I0FDN
M>G>FW3ERKVD)1E:-[&-XA^)2Z$-<3[#I,!TGQ78^%UU#Q#XB'A[PXAN_"NG^
M*#J.M:X=)NQHL&V]-A"@M[LSW36J`H+DF#F4KQPTKPA[?ZSI.7)_N]:='DIN
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M^QJ*,E*,;ODDD^91;C=\KNDW&^S:.`\/>+O%E_>^(8];\+Z%IFG>%[N>PU.Y
MT3Q/KOB;4I;J+1]/UI!IFBQ^`K&34(WM]2A3:DRSF1'2."4E-]0471IU6W%5
MW.--*-_?IXJ>%E[1W2IPYJ=2?/[R4>5S4$YRIMJ?MHT(J-[4W)RDH)1J0<HM
M-JU[\JDI.$4FY<SY4I=UJ&J6&DP07-_.;:"XO=/TZ%C#/(6O-5O(-/L(2D4;
M,AEO+F&/<RA4W[G*JI(27[R%&/\`$J.:BN_LZ52M/7;2G2G+?7ELKR<4TFO9
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MM4XIU/=]K&A*BH>\Y_6)8J*4W[L:;C'`XNI)Q=2+A"GR2E.KR0JR_%F7[5X>
M@M/#]NW]KQV'GV=[KOV'7)[R;5[C1]8T_P`)Z4FD3Q^*[G0YK.XGU+_2]/6W
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M/`^M^,WT[P_KR:4EV\-G\//%Z>,[20V6G-J5VFIZW+H>E6NC-;P)(\N_SAL"
M+"9KFXM[:?IG#DGAJ>M\36C3C-Q<:7).K&C&JIOWIIU'*+C&GS)I63_>>SSP
MJ^LU%#2FK4[QNG54ZCLJ;I+3F]Z"7O\`+K*=25.E"54V?%'BGQ5H=YH\>E^&
MO#^KV>MW^FZ79"X\6:GIFL27=YOEO633+?P5?VYL[&PANKV69]0C_<6<Q"!P
MB233C?%+#5/<@Y5'SQ7.X4:5/GJ5:D7R*'O_`+F"YW&=:IAZ?M%.O&*QC4YL
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M?1&=-(6TU*TOQ<OID;^3*`\,;9"IRC_L+IR2IXUUDI56J7)*@L5&M%I<Z;]O
M@ZM&E9KVMZ<[QYN5.,7?%PDGSX2,9.--.?,JE*C7IVOR._LL13=32T)*<4YQ
MBIRV_"/BY_$5@E[,WA>YBN=2DTVRN?`OB:]\>:298;-[R8:AJT'AK38M*=%C
M93YR^5ND@3SA+<Q1/JX6C#2493C.:YH\L'3C*,%*$V[3DYN<>1*_N2<>?EJ*
MGFI:U;.+C2Y$[2O-3DTN5P2NK*=.>C;Y).<E"G'G?4W>IV-A<Z99W4_E7&L7
M<MCIL?E3/]HNH;&[U*6+?'&RP[;*QNI-TK(I\K:"795;.*O*4(_%&G*JUM:G
M"=*G*7;2=:FK?$^:Z32DU;]V/.](J487_O3ORJV^MGKLNK1A:7XI&I^*/$'A
MM=)U"R70K#2;Y-1O52WCU0:G>:W8NUC9D^>EI#<:).BW$ZQ?:"3)`CVQAN+E
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M0TRZ\8ZA;3SZ[I^N3>'[;3_#<MEX)ODUN._U")8[>:X&F'=,BRQQ`2-&+66"
M]FKPQT,-*E?2I&5:[G[2"YHQI48+V[KQJ3A+"J>(:A3C=B23KQJ25-X64_:2
MUE35.-.%6,XR2]I*;C/DG15+VD:Z=""JU&D^NA\5S_\`"5:;X3N=$N[:YNO#
MVH:S<ZF)0=)CO=-DT&.ZTK399X8+C5A'_;T#->K;00<+&K-<+<PV5QC&3QGL
MY/V>%E347)<LZD:LJJC/D3ER+]U)-2E>_P`*E"TW'OPH86K.'+4KSC"4(M25
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MR<5.$K1;C-)2CS1C))I3C&2<5K5!84`<1X[\)7'B_3K&RMKW2K,VE[=3SQZU
MHMUKNFWUG?:%K.@WMC<65CKND3*)+769666.\4HT2_*<\9RI\TI.ZY)T9T9+
MWE)*56A5C.G.$HRIU(3H1<9KWHOWHN,E&2UIU'2YG&ZG>#BTU:,H5(S]Z,HR
M4XM1<91=DT];J\7D^$/`VK^'+S1FO-7\.3:5X<\/ZAX?T72M`\+:MH?D0ZC=
M:/<RSW=[JWC779;Z0?V/'RP21WN)9)978\]/M/\`>)23=3$?5HW7+&$(895X
MPA&G&*45:MRQ47&,(0C&,;;<T::IQA3IVA3C4G5:LW)SGSMOF<M$Y5)R:L[M
MJSBE9^FUD:'$>./#6M>*+&RT_2];TS2K-+SS]9L=6T&[UVPU^S6)A'I5]#8^
M(M'F73C<,DL\*W!2Z6$6]PLEK+/!<2E*->E53CRTE)QC*+=JMX.E63YDN:C:
M?(I1G%3G&K%1JT:4XVI6IU(1YH5)\J52,N648:^TC'2\7434>>+C.$>;D:E)
M2CB:GX`UC5+B=IO$FGP66O6.@V?C2QMO#DJKJPT.>20_V#--X@E;P]!>V\KV
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MEI%UJ<DY93I,MREO=SP1W29B>`H^Y]757]Y3P:C&C%>Y>%*-J$*_Q*K"B^6*
MC%4E6I4J5+$JLGB)8@J^^L0X?NZF*BHSEOR/DA2G4HI<OLZDZ<.;GFZKCB*E
M2O&S]G&G':_#V\@UBWFFUZVG\.Z5J_B/Q#H>C+HABU.RUCQ-#J45ZU[KK:M)
M'?Z?"=<UIH((].M)1]JA$ES*+?\`>Y.E?"5,/*7[QX*IE].HE90P\ITG#GA]
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MW=.7O<Z<H1=.=KZ24:L6XZ*47[Q2;X8VD6D>(-$L-4FM[/6/`VB^"+9KBU6Z
MN+*+1H=;A74KB1;B$7]Q.-9WN@2V&^!B&_>XCV=3WXRY8Q4<PHXY1@G&$8T5
M@E'#P3;<8*."48R;;C&:7++DO.DVIQG)N<_9XB$Y2LG.IB)U*E2J^51C%N=6
M4G&,8QOI%0C9)=;^%VF:[J^O7]YJ%U'9:_X;OM%N-,@AA$<.J:E80Z->^)(Y
M9O,5M1;0[/3[%(WA,:I;.6#^<RCG=/\`=XJ$6E.K4A4HRE%35!*I2KU:7LY7
MA.A7Q.&PV(J4VHIU(56[NO.2=.7LW@FU=8114E=Q]HH*O&G9Q:E3<8XS&1<H
MMRDJM.SBZ,7)?!W@F]\$)'#8Q^#E&I:G!_;)\,^!]/\`!EB-+L])OD@E6TLM
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M4E*_-*<9QER>SZIO!<7_``KZ]\"17-E9)>^'M4T,WFFZ)9:7I]K+JMM=0S7-
MEH.G-!!;6J37<CI:K+NVJ%DGDD+S/K4ESU*$[R:P\\+)<\N><HX65)Q4Y)1C
MS35)*3A"%.+D_9484U&DGA)?5*M.KRQ?)5E5Y8+V<;RJ2J.,5[S23E92DYS?
MQ5)3FY2>9XD\!7^NW5VD&MZ9I^D:S9Z+8>(('\+6ESKMQ::+=RW4,6E>(XK^
MV>Q#^?,!]OM=7^SO*\MG]G=V)FF^2O&I+6E3Q5/&P@O<?UBBZ4J?M)*\9TE/
M#T)-*G"O**J4WB/9NC'#X*ERX6GAU+WHX2I@G.2NO8U83A5=.-U*G4E&I/\`
MY>2HJ4:4W1<HU77R)_A3/>PS:7?^)?,T"RC\1GPO96NC);:EHU[XBGDG^W:A
MJ<VI7$.M/IZSW,-HBV-DIBN'%W]J?]Y44E*C"BXM?6<)2P=##S:?LX4L#6PU
M>@JE)23J3E/`X)5I*K34E1J>SC1]N^7>?).I44J=\-B*M:O6I7:E*IB:&(H8
MA0J*WLZ=18S%SY>2<H3J4^2:A2Y)]-HN@>(M(OY=3OM4TW6]5UW4[1-?O+;1
M9=&L;70M+T>_ATZSTJPEUZ\FMI%U-TF>6:YOS(VHW($44;(UKI%PA#V48N,'
M.O7FW*[EB*JH4XN.EHTXT*%*DJ=KOD=65;G;A4RY9:SE+FJPI4:%-VY5[.G7
MG5FZMG[U1K$8EJ4%3CS.C'V:C&<I8VH^`-<O[SQ-;CQ)H\7A;Q9K-EJ^JZ6_
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M7AL-,NM6EU?3[B07<;7>GZI:ZJ$:`^6L,]A:70,DD$81T7[%U7%:5Z\ZE9;*
MI2G0P]*-)]I4:E!5Z-5:PG)P<949UZ=?.4>:E1I-_P"[4N6F_P"2JI.2JI=%
M)-TJL-ZE&4XJ=.?)4I\9)\$K'[5XIDM[KPW:Q>(8?%)@OX_`NE'Q=:W7BSSV
MNQJ/BS[8)]4TVVDO+SR+>&#3YO*:&&>ZG2$B58;_`&:GA::_YA)85+D_=QJ4
M\+BZ.)A[6,?CK<N'IT?:)QI.\ZU3#U*[A4IZ57SUO;6U?-)\WOM2EAIX=^S;
M_APESNK*-I3YO<IU*=%RI/9F^%MDOC>?QG&OAVX-Q?6&L7"7O@O1]1\5)J&F
M:;!I\5OH?BZ]N@=(TV9;*RD:!K.:9)?M#07EN+C]RJ3^K4ZJ4'42>*G"-/EI
MSFL3&?/2K2;2JQ4JE65/WJ+;E3IUZE3#PE2G$H*K'#TG)0]G&A3E*:<X15"J
MIQJ0A9^SFTHPFTJBY8\].G&O^]+_`,.?"<V@Z'JWVRUN].O-=U/4KB*PO[BP
MO+O1-$66:U\/:&TVES26A2RTP1GRK>>=$>YE03S8\UXK4>;+J>`55.7U?DJ5
M4I/FJSHPHJ<N;E<ZE+#T\-AJE3W%7EAO;*,/:65QJ?[;5Q?(XJ512A&7*FES
MRKU5[KDE&IC*V+KT[N4HTZ\8/E4%2IZ%OX(6'2?A]I3:CYB>!7M&:7['Y?\`
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M!I6J7>J3V`GDL%CAF5"9;0S.]Y'K&=J:I2YI1C[2492ES.%^3DITVXN:IINH
MW2E)TTG'V/L.24,1,TW*556C4M%+E7*IRE4I>TG7L[5)1H0E&C-1513;56=2
MG**I.\3?#&'Q'HWC33#K$EA=^*=5FU;3]5@L(I9]!FN/#>G^&;F)8IK@K?PW
M&GVMY#,-UL7AU.6-3&Z+-6=->R_LYK?`5IU'T5:G5QM3&3HS72/[R*BVY*->
MC1Q*CSTXP6\*O)6G5Y=X4E%7MR5:$?W-5/O"HHS<;6G#GHS<J=2:>G:^#=4B
M\36VK7GB1M0T;3+W4=5T?2)]/F_M&PU'5-,72[B)M;?5I(YM%B@EU!K>Q73H
M7B:]`-PZ0*A=)^S]K)^]4E3KT8RVM2Q&-IXZ2J7NZE2G4I4Z-&:E3A##05)T
MIR4:D>54E&CAJ,7RJA*A4EIHYX?!U<%'V<5;V4:D*CJU8OVCE7<YJ<5/ECJ>
M)O#^H:M+HVHZ+JMKH^M:#>7-Q97.H:5)K6FRPWUC/87MI>Z;#J>G2RH\4RR(
M\-[;NDMO&27C,D4N?+.-1U*<U!SHU</+W;OV=6I0K-PU2C4C6PU&492C4ARJ
M<'3?.I0V?*Z;IRB_=J4ZT&G9PJ4U4A=JS4HRHUJU.4=/XBG&2E"+*.B>"(]&
MG\,2'4I;U/#>DZS:A)K9(Y+[6M?N[.[U'Q!(\4H2"XD:+4%$*1$*-5F"N`,/
MLG"$JKI0]G#ZOAL)0BY.3HX;#I)TW)J]1U52P;G-J+YL*I6?M&HPU*2CS-7E
MB:^+J\L;*5>LZC3@G*3IPI_6,4E!RJ.4:L%*=Z7-/EIOA=J/]KZQKUAKWA_2
M=<N4UAM%UO3_``'IMKJ]O?ZN);=-4\3W<&IQIXLO=/T^XNK6R/DZ:BK=2R7*
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M^G6/ASP_K7A^ST>SLHK>U2VU:X\.S0_9O)=([."UCT!8E@2`J5N1@H(L2:*<
MN;%SG)U)XI4$W)MM.C*O)MMW<G/VW6UN6]W?1-15&%*,5!0KJOHDE=4L13:L
MK6<G7<W+O%W3<KK)U#P[J$OB#Q!-:/Y-EXK\*6^E7%^;?3KU-)U+1YM16T>?
M3M09DU&UO+77)PT/DR)_Q+660H+A2,>2]#%X:2AR3K1Q$%4ASTZDJE*EA\10
MK04HR=*5/"X?2,J<ITYXE*M2J*E)VWRU<-7BY1G"$Z$W"7)4A!2G6P]6E)QE
M&,Z-2KB6Y24_WD\->C5I1J\O*:9\)[G0_(U/0]5\-:)XEMM1^U6[Z3X(&G>#
MH-/.G7FFOI,/A&T\11SQ0/\`;[J]:<:SYQO9WDW_`&=C:F[SC%1I3E%RAB(5
M93?.VL1+"2;I+W8T?9_V?@HTTXU(6IU7.,IUW*&;A"3DYP7,O8.FX+D<94'B
M6I5+\WM92AC,52D_<_=SI<JC.BIR>GPD>W>TAM_$2?V?/;^&5\2K=Z)%<:IJ
MU[X7\0WOBJWO],U&/4(8=$>\UK4+N2ZBDLM00I)BW%M)F9KIRA2JTO9PY<+A
M:E.KAZ7,^>$J."I8&E&I6?\`$IQHX?#\T5"G.<HUFZBC7<8.:E.%1MJ->O#&
M4ZLDG[-PQ]6I5K^SI.3=*:E7K>SG[2?NN@JRK+#POT47A:[U2U\>G4A'I\OB
M^]DMX(+FRTK6(;73-/TZVT:P>\L+H75EJ$=U]DFO'@E!S#?I"XCEC;9C&,H8
M:C&#4,1]8>-GS)RA&OST51BTG"5H8?"82G6]E4A)5HUI8;$)^RQ!HY?[1*7O
M*G&A'"Q<)<DY4[5IU*B;4E&7M<575-3A.#IPINM2DI5*3JCP#J-WI'CNVUK7
M[*YUCQUI+:-<7VDZ`^D:3IMI'I%SI5DUMHTVM7T\\\8O)Y99)]39I?W<2F&.
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M;UCQ;877B6PMM%M?#VJ6?A8Z?;6JZ-JQUA9M?TW_`(2"8:[/=S8BF^SSZ5&D
M<D_V..UDFWK4+TI.M34(XB=2$ZEE+V'+'#8S".%*DYNI"]',,6E.IB*TU+ZN
MVY*A*-:9)3C[&;E*A"G4C#5*LIU*F%K*I.<8JG*4*N"PLXQC0IP;C6C*+A5C
M&EN1>!9SHOV&]UE+G5;KQAIGC+5]4ATPVMO>7VGZWIVJBTM--.H2M8V8L],M
M-/A\R[NI(XX4>1YW#%Z@XTI8#V<6J>`C724I7E.6)I8Q5IRDHQ2YJ^-JUU%0
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MW-=?%:VEVFH\N%A&*A'#*O%)*RM6^KV22LHJ"P]DE>_-TY=>.O\`P7J%[-XK
MT^*=;&WU+Q'X<\<:)J\UM!J-I;:YI1TGS--U#2OMUO/>VJW7ARSN'"O;;X]3
M*0W$<T`=)I<].GAN5J%7`5L3[+F3E&=#&?6)U+J,HM5(RQN,A%WBH-86JO:V
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MQ4*5:59N[4)0E&3J2J&U<Z']H\3:/XB^U>7_`&3HVOZ1]C\C=Y_]N7?A^Z^T
M?:/.'E>1_86WR_*??]JSN3RL213?L_K/7ZQ&A'MR^PE7E?SYO;6Z6Y>M]-)/
MFI0I[<E>-:_?EHUZ7+;I?V_->_V;6]ZZY_Q;X1UGQ0TFGGQ':VWA>_.E_P!J
MZ-<:`EYJ`&G7\=ZYT/6X-3M/[*DNO*B622[M-4:(QB2V,#TJ2Y*]&K/WHX:O
M2Q-)+W)1JT7"=.,IZJ5#VE.$Y04(5I*=>F\1R5*4:"J*]*I3A[CKT:N'J7UB
MZ=:$Z=248KEE&LZ=6<5)SE23C1E[%N-7V_-W_P`%/#-U?7]S;7NNV5KJ.B>(
M=+GL&U_Q%JEJE[XAU*VU2XU2"SUC6;JP1%NXIIFL6L6MI9IUF=-T*5-)2H4W
M"BU>F\ME0<TZBI/+*M2M04^9\]6',Z,5^\A.G2IU:=.I%8JLRIN-2M3JU(W7
M^V*M&+=/VL<;3I4JB3A94OW<*B]V+4I3I3<>;#4;3_\`"N=<;41XIE\3:,WC
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M7JSK5.2+E)QASU)<D7*<HQLI3FTY/?J2@H`\J^*7_")X\$?\)O\`\([_`,(W
M_P`)@_V[_A*O[-_L/?\`\(AXL^R_:_[7_P!%W?:O)\OS.?,V;?FQ44_9?6G[
M3EYOJF(]GS6OS_6,%\%]>;DY_AUY.;I<T7M/88CV?-:U+FY;_![>E?FM]F]K
MWTO8P/"G_"JO^%A:7_PK3_A7V[_A$?%/]L?\(-_PCF[;_:_@[[#_`&E_8'.,
M_:_*\_\`Z:[/XJWH^T]EF'Q>QO@;;\G/_M][?9YN7EOUM:^EC&?L[4?A]K[5
M\NW/R>RJ<UNO+?DYK:7Y;ZV/=*S*/(/BM_PB?VGX>_\`";_\([_PC?\`PEMY
M]N_X2K^S?[#W_P#"'^)_LOVO^U_]%W?:O)\OS.?,V;?FQ4TO9?6Y>TY>;ZCB
M?9\UK\_UK+_@OKS<G/\`#KR<W2Y<O:?5:GL^:WML/S<M_@O4OS6^S>U[Z7L<
M?I7B?3_"MW97>BZKIVB?">[^(=]8VE^SV5MX5CTIO`3W,D>CZA<J+:PT"3QM
M;7"V[V<L-N]UY\,+-'*J/K2E/]S3Q?/[2>&QOL(S4W6G-8W#/"047^]J5'A7
MC)82C%24\!'#RI0E3ITG'*I&'LYSP:5J<\)[=T[.$92EBX8F22]Q+WL`L1*F
MK1Q+JNJUB'BV9L?BWQWJ6B:WK\7BZ^TU?#7P\T;Q5%81:)X>5-5U:XU#Q:;B
M+6$U'0I+B"QDM=%LX7@M)+&927*R1N#NG"1DJ66U*]JDZ^)R>A4A=*#6)P64
M5<6W*FTW*=3&5)4I4Y1A3<IZ5(>RC2TJ<DJM>C1ERP_X57&I%IN*P^*Q-+"<
ME^:$HQA!>TYXR=10IVDFZDI:7C/Q!<W7B;^R;_Q1_9TUEX_^'%OI'@@6>F_\
M3C0Y-4\+ZA+XGWR6AU1]NKSWUI]MANTT^/\`L_[))`;MC(7@E?$X22_>U%5S
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M%>J^%OB!H;W%@D3P7=AXLLG\VW2ZN=-U.[MO`7AK2;EX)4M9EM8[">XMVF(N
MI-QA`ZZU&"I04Z:YX5JBC*R<)PIJDZ=2$G.2K-5)58_6*,88=J$:=/FK4<1)
M\E*K5565I>SO0IN4%>$X3J.O"I"4+<U*,J:@O85:E2LKRE4?LZM*_*Z=8V7@
M7X9>(?$7@OP_X<T/6V\3^(-,N]9M=+L-+>RT-?B1J&G7%W>7]KHE\8;'2M(,
MDR27%CJ%M9I9K++:S6]N\3X.I-4<FI>U]C2Q>'RYUIN:A'VDL`I0G4G*$X*5
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MA,#5]HH.#J-^QYU*G._LX3I.48PLJE*<W.4YI1IQ@F\3>/\`3K*+Q%!KUWKL
M^I^(OB=HMEX5?2-$&F1P>&[?QI<:";5M/TF#59]163PY9HX>_E29)I$$0E99
M1RQ?)AJ/M*O(ZV54,75Q#AS?5YU*N6JIB(4H64HT</BJM2=*2G[2I%N'LXN%
M*'6X1EB*D81Y84,;2HQAS*/M83ISYJ<YSNH2E6LJ=6+BH0C%U(S?.WC_`/"P
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M4L;6M)NO'V52>)A^\G*.`^HWQJJ*H[U/DC1K-5;8:/\`:3CBTE/E]A=X>*2M
M2GRQLU97Q^GU>4.63>/#XP\7Z3J%GH^EZUH?AZS.L^)+W3[?6-16S/BO4KSX
MG^++34M(M+,>!==N_$DEO!#IR?8M'O-&O(O[3$KR2I/$;6<$E4^H0E[\:>'R
MFDZ25Y_5JF`PSEB(TU[-K?$+ZQ*O+"X=T%/%4XTH3=98IRA3Q=2,?9593QDY
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M/!9%3Q-&?N2A&="C2Q+J4[1J)8:.'JK$U'5P\<`N:=:-=SBJ!&$:OUWV<N5X
MG,<SC3JQU2;Q6)=*TW>FI5IS@J$'"M4Q<TJ="%HUI'9WFN^+M3\1SIIWC>^T
MW2;WQ?-X>L[?3-+\*W4-MID?PSM_&27MG=ZCH=W)/?2:BI5)9I)X/(N9%^SN
MWER19554P^&Q,Y-^UH83-,1:45%QG@<T6%I0<;*UX-PK73<H)*'LJMZTIHSC
M56%FH**J++[I-M/ZY2DZC;O>T-)T5%QY:JYJCJT7[`PM2^(7CEY_`H@UW0=#
M_M3P9X.UV)-5O4TU?%^MZO.Z:SIMGIT?@77;G7VB1;`?V?HMYHUW!_:@D:26
M.>(VO>Z<%FN-H*/[JAC8450C>4XX6?*W6C%N$_=_?Q^LSKRPU!T(U,7"-.,W
M7QFY0RZ%2+_>>SQ3=:5HQ]K1452A)I2BG)^_*E&C[3$\[IX5QG!I=MX$\87N
MH>-_$&@:AXHM_$SJ-7O;1?#>K^#M:\,Z+8VVK1P6EC?1:7I5EK_A_7T@G2)[
M;5)-3MIC!*T%\TJ/#%RX7]Y@?:?%."H.=7>G-U(-MX:K3Y:4J4YN3C3JPC7C
M3IQ<'6A&K6EMB/W6)45[D92G"-)>[4ARW?-7ISO-.FH1A.K2FZ3K5K3I4.>C
M3CSD/C3PS:_#GQSH=OXC\,2>*;2X^*LR^'+B_P!$O]3WQ>(_$U[BY\.WCRM<
M1?9L3-%/:NC1'<RE#RZ'[VGD+I>_",,BC-PUY$Y8&C-N4?X<HRERJ:<94ZEN
M64:BBUHU[/%X]5/W?-4Q+C?W>:]&4HVVYE*VRNI*ZU5S7O\`6O&,&K>(-6@\
M372Z=HOQ%\(>%;'PQ'IN@?V9=:9K=IX134!?7<FD'4OM7GZ_=20207\"QM'&
M'65,QUG%SA2P\^7ZQ5Q/]KV@TTO]EAF;PRBH6DZBJ86',W)QG#EA[-3YZE3%
MV]G.,7[!4,+@ZO.E=\]25+VJ<7>/LG3=HJ*A.,Y3:ERJ$5YG-XQU6XO=+U>+
MXEZ';>(6\$ZE)K/_``D%SX<\,V/@K5;OQ-X)?6O"46I3>'KV#2;](HY[6"UU
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M.,36T</7I0=&E%ZJ4%B)XN@Y-NLO[/IRFTJ[=7S?PYX'N]3+ZU9^$O`FCO:>
M/O&&J3>/+6]F/CNZM+#Q?X@^U:>]G#X2@'EWL*-IDOFZ]/']CF=C&Y"P#BJ_
MN<IHR?[F$<G7-2I:PK^VRITX^U_AI6J588N5X5;5Z45'W^7$0[)?O,9B*:_>
M2EC*-I5-/9>SQ.'JMPMSNZC3E"&L$^:TTZ?/3GE+X^UKP[;_``JTW3M=MK&Q
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MN,HM7H\S]E&-&K4J5U.5Y/DJT4_//$?_``KO^TOBW]N_X1G_`(6;_;@_X0[R
M?[-_X6'_`&G_`,(9X8_X1[_A'/*_XF^_^V/]7]G_`'>?.\S]UYU<V&Y_J^`^
MI6^L_6:_M.3;_D;8CG^M<FOU?ZO_`+U[3W/J7/[3]S<ZY^Q^M+Z]_N7LL-?G
MO;D]G[WL;>][;F_@^P_?_6/9^P_?\AUDOC_5K37K[PU>:W:Q:]'\0+"SAT=8
M;`WR^$+CP;97[W:VHMS-_9#ZY).BZE(,><XMA/N*Q5G7J?N*<\,W>G'.G7>E
MX.A0S>O@(U%\,*GLJ6!K4Z>DJU*+JN-2FZTGE3C4AI77*YTLH=.]DISK8C!4
M,;R-:2?.\7"23?L]9044J;7.1>*_'6DZ'X7O]0\97=\?%G@?3?$&L7USHWAR
M.W\()+KW@RRU;6M)2PT6V`M;+1O$>I7,C:M_:,$36$=Q*HMXIHI.VM3I4L9B
M\).I[*CA\1A(.NVHN/M(9FY4[RO2A3KXC"X>A2E4C*=*-2TJM2H_:-1<I4XU
MJ<.>3^O1A1LVJGLHQE0DTG[1U(14IU(4YI5Y-TZ48-PMRD_C37M+FUM=`\=:
M2FD:GXLUR=O'VLZAHV@6NK7FF^$?`BZ/8C4AX#U_2;R2[M9]0F$%AIE@VH_V
M>9=/GA2-X9^>#J^QPT/9*G4I4<34HT'"K)XARS7'QDU0C_M&(=OJ\O98:O2J
M36(<Z4'3E!T-'&G[2JU)U$Y82G.HI4XJC!X:<I7JZ4J?OIP5:K3G3H^S]C73
MK2YGWMMXU\<3?$2PT>\UKP[I42W/A^!O"\MY<VMYKFF7_AZTO]6UG3/#MUX`
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M+)2VDK/5'G%U_P`(#OT;^TO^$7_X5-_PM&]_X1_^W/[-_P"$)^R_\*VU#[7_
M`&/_`&G_`,2[^P_^$J^W_9_(_P!'^U>?]F^7954OCI?6_P#>/J>/]C[;^+[/
M^T,%["_M/?YO9>U^KVT_L_ZO[/\`<<I$[>SJ_5/X7-@_;>R_A^W]IBO;?#[G
M\/ZM[?D]SZS[7VO^U?6#:O;+3KSX8_%T>&;VYLO!%JNOWWA,:!=/9:1<VEIX
M.MI;^VT2XM0-OA;_`(2@7THCTZ6&WFE@NH09+*66"=KVB65RK\SK+&4THU.;
MF=">/C"C[:,]9+V<IK#1G>G]2>$E3BX1HM=&!]E_:%&%#E5.:H1J.G91CB'6
MJ>W=)KW(U'1]A&M.GK#$2KSYH8]5IQZKXMP6-UI/@Z#5M3\%:1HRZ^EWJ5S\
M0=+NM6\+R);Z!JZ6MK>6BW=A92SM>W$$D,=_J=@C/`#$9Y46WERJ^S6-4JC@
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M3IDNI2>`O!CR0M<3Z9/>V%F;@L-TMA)/&N-\&\%*WJQ5/#X>%!7A"MCXQ4YQ
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M"1ZAK<U_I]HRZE"_BR*?RH]/C0V<7E20O)JYENF@DLX_+]JO_P`E%B)5/W<I
M8C,*=.,M8PA4RW&U*]1\G/>K2G)TYV2]G2PN*^KSQ?UNE$\>C[N0T(T_>4:.
M!G-QTE)TL=@XT:<>;E2IUTN=<WO.=7"^U^K*CB#V;QE9'_A+OAAJ/VW4/E\6
M7=BE@MT\6F*)/!/C6XGN9+.$(MW=R-#;*)+HS^2MOBV$)N+DW/#A],577\V"
MKO77EY*V$2Y5M%^_+FDDI23Y92<5&*]"KK@L0OAY)X66FCDWCL)%*3WY8IRM
M!6BY2YIQG*%)T_&_$,OAFU\0>))O!8M=1N+KP?\`$-/%.F>&_M6E^.K*^4PW
M,]_XSU"]CU#4;M7OHS:Z7%<V-LUJMVS6D5[;NB6V%#D]C7A>G'`26!E[2<;X
M.DHXS#PJPQU.Z57$2A6Q5?'.K4AB'A\/C\/B80K3KXA:/F^LX=I2^N>VJ+D5
MEB9VPV*<7A)2E!4\+S0PU*C""^K2KU,!7IUH4H4J=2C:W?PQTKP_JD6MP?#_
M`%O3+SQ?%;^%(K6:S\-?"?6-8?PI8+=ZC::;=WEYI.F66G0R7*7]U)<ZM+]L
MM9GM4&H3V^GKK5@JM+#T92=&M5^O*G*M+FE2P\:M&%6OAE>$U3]HE'#TJ%IJ
MK4Q$88A4*^*Q"PHVAS5HW]C&CA958T5[\JSGBE##U[J/M<1*"A.I*O&E3]@L
M).M0A]5I5'W_`(GF^'>@_#WP+IWBF^\-^,K;[-9:=X6F\1ZS:0>%M<U!-(>`
M:QJ%[J%W<:?_`&5!8M-<"ZN/MTD*E%LEN+Z6WCN'C;8C&2IR_<8FO2JVG6_B
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M5.;VZP^=O&>RTGSVS%8#ZQRZ\_.\G^JJ7O\`+]7=)>SBVMY<GUK_`&GE]ESY
M3]5Y[6]E[?!?7/8?WK_VI]8Y?WGLO;>T_<\IR/A[4?A[HNC:DWBBV\&ZKI-Q
MH?ANZ\0+HR7VE3'Q8NK$67A+XEOK'B&2RU[Q1/J-Q<2SW>N)I9`L;^34[:"U
M3,7?B/JZG.GAU2>'CB:,,`U*,<!6YJ&.][#P:J4Z?U7#4HUJTZ<J]:HJN"GR
M/%8?!^TYJ*K<\77E.&(C2Q,L:W=XJBX5L+SNK*ERSE'%5I5:=&E&"IM4\10H
M2J4*U9/TV2STNV^`WBV#1M2T+4]/G\/^,[F`>'KZ+6/#6FC4)-2NVT'2+F!U
M2XTO36G-D@5;<%;8X@M@PABBO3DY970DW4Y:^648U*\&_;1CB\/!5*D'*\Z;
MMRQ@ZDG[*,:<JLY1=1ZX24?;8FK"*HI^VG[*G*,72?U?;W;QA5J6]O5Y4X^V
MJSE&\6FTOM$/PO\`!^N:M:_\*\\.:A?7&@:=%KG@[P)IG@*WLH;W5+>R,FN7
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MQ`5U[N`@W&%*.-H<TH\TKSJX7'QFY)Q@[4*;4HPC'3V>+:J595</2-'X6S^(
M7\:>/'\2Z%KNDZOJ.E^$]3U+^TKWP]=65G<M)X@B@TW3!HWB#4-EA%:[(;=O
M+C,@TZ>XNEBN+G$^E*$(Y?4IPJ<WL\?63FX\M2I.>!RZ52;C[\8N,DI1IN<X
MTJ%7#4(5*[I573BJY?7HR<.53P5+EBFG&$(8S'QIZW3;J1;<Y)+FKPQ$W"C3
MG0C)(+'PU8VOQ4L?&%_+=Z$/'>BF]OO$L]]?V#7,_A#P3>13>(/L\D-O%H!U
M.16FM93::7'"WV<I!:A8UPER?4<`G[.$E/&1I.K'GI>TCB<5&E*KSR2J37+'
MV3JS]I/$*@J,UBOJ[75/F^M<R4^6I@J#G&DW&:I/&8R,H4>52E",8)*I*$9/
MV7MJN)<XRQ,Y>.:H=*D\,V%G>'PS/I-I'\3AX8O[JTAE\)^(YTU739-/L/A?
MI88IX?\`$4[7-S::%<0W6KO91Z?=K;VNKI,98M%SMX9N-:.,=#!0IT^=K,9)
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MDJS_`&82'2T>!=IPH*$L-A(MPCE_U/*5CG+_`'98N6,RQ8QXE1E!.JJ2SIXR
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M9[GQW%9W%O/=W\4:ZPVN6]_<07$EH`FIS06\GG1]-54/K=1T71CDRQM/ZDVH
MO!>[@<UE'V$5*-)Q=5Y*H--TG7>%5ISC*!G#VZH+VJF\U^KXOZXHM1Q/-]9R
M[VRFTI34?9?VK[%PB[4_K+PBO8Z>'PYX1\4^$]%\.OX8\$7_`/:WC+5O#6B:
M_HV@6YT5O#V;GQ!X@UKP3'JD^IMX?M)K*TU"TB%A>S017P,]LY`0K,8<]?`2
MG3G3E&C5Q%>-1WK+#X/%5H8>$YRC&I/#XK$5,(Z=*2_=Y=CO98>?LH4JI2J>
MRAC73E"2C5HTZ#C%>REB,10P_M91IWG2=7#4XXB59-.-:O@:GUB'/*K`^G[:
MVM[.W@M+2&*VM;6&*VMK>!%BAM[>!%BAAAC0!8XDC5555``"@#@4ISG4G.I.
M3E.;<I2;NW)N[;?5MN[8J=.%*G"E3CRTZ<5&*[1BDDM==$DB:I+"@`H`*`"@
M`H`*`"@`H`*`"@`H`*`*%WI=C>W.F7EU!YEQHUW+?:;)YLT?V:ZFL;O399=D
M<BK-NLKZZCVRJZCS=P`=592/N2E./NRE3E2;_P"G<YTJDHVVUG1IN_Q+ELFD
MY)CUCR/X>:,[;>]"_*^^G,]-G?5,OT`%`$%O:P6B/';IY://<W+C<[$SW<\E
MS<.6=B?FFE<XSA00J@*H`-DDM%%67]=V[MMZR;<FVVV'5R^U*UWU=HJ$;ORA
M&,5VC&,5HDB>@`H`*`"@`H`*`"@`H`R=*T/3=$_M#^SXID?5-0FU74)KJ^OM
M0N;J^GCA@,LEUJ-S/-Y:6]O;P10AQ%!#;Q0PI'%&J*1]RE1HQTIT(N,%N[2G
M*I)RD_>G.4YRE*I-RG)OWI.RL/6I.H_CGOV25VHPC\-.FG*4E3IJ,%*<Y**E
M.3>M0`4`%`%(+8Z@+6ZC>&[2TNII;:6";S(DNHDNM/FYA?9(\?FW43(^X(X/
M`>,%;G2J49\M2G*E445[LXN,E&I&,D[22:YH-.,K7<).SY9NZNK3A?12<9+I
MS4ZFL9+^:G5@KQ>L:D%HI1TNU`R&*X@F,RP30RM;3&WN%BD20P3A(Y3#,$8F
M*;RI8GV-AMLBG&&&;G3J4U!SIRIJI'G@Y1<5.#;CS1NES1YHR7,KJ\6KW3%=
M7E&_O0LI+K%RC&:NNG-"49J^\91DM&F35`PH`*35TUWTT;3^]:KU6J`I1K8Z
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MB4O+/<7$S+'#"B`LSNRJ`"2<5-"A6Q%:GA\-1G7KUI*%.E3A*=2<Y.T8PA%.
M4I2>BC%-MZ)#MO9?"FWY))RDWV22;;V23;T*>D:[HFOVS7N@ZQI6MV<<S6[W
M>D:A::E;)<(B2/`T]E-(BS*DD;%"VX"121AAG?&Y?C\LJJAF.!Q&7UY14U3Q
M-&I0FX-M*:A5C&3BW&24DK-IJ]TR(5*<[^SG&7+H^62=FU=7L]+K77H:M<99
M3O1931G3KR2(+J<=Q9K;O/Y$MVK6\K7$,&R1)&<6RRN?*.Y51FR`N1<:52<9
MSC3E*G1Y93:BW&"<E&+GHXJ,I.,;2]V3DH.][-J3IN$E+V;YDHM/E?/:4THO
M3W^6$YI+WK0E):1;5L`````````#``'```Z#%0V[W>Y,8QC%1BE&,4DDE9)+
M1)):)):)+8BFN(+8(T\T-NLDT5O&TTB1!Y[AUB@A0NP#322LJ(@RS,P`!)JX
M4ZE1R5*G*HX1E-J,7)QA!.4Y-).T8Q3E*3TBDVVD#:BG)OEC'E3;T2<Y1A&[
MV7-.481[RE&*NVD35`PH`*`"@`H`*`"@`H`*`"@`H`*`"@`H`*`"@`H`*`"@
M`H`*`"@`H`*`"@`H`*`"@`H`*`"@`H`*`"@`H`*`"@`H`*`"@`H`*`"@`H`*
M`"@`H`*`"@`H`*`"@#YPU?Q7'9>-+VT;XA^&[31;;6H=,FM+KX@Z-9W=G97M
MVNK>)YKJTDUB.YMKW3[_`$H:/:P&+S8(M7E6/;"CB']1P632K9#0K1X9QM7'
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MGCOX+Z'_`$B1-/M3,B7.Z\N([H6Q5'(,RIX#*HOAG$5:=.=!8C"/(,9]?YN>
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MC"5.5*,YRP\ER2P?N0E&-.FU*.)Z=O'.@PZ)J%K+XTT*\N+_`%RPU74WTCQ_
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MX?GKWQ$:&$;C[9/_`&EUW#%)I3Y9KZKRVC+FI\R]I3OB'*;]NUJT\9SW43>'
M->\,:59+"JS6^M>$=5UZZ>X$DA>6*[L?&VCQPPF(Q*(FMI&#(S&0APB?E<-)
MWJ>]3NO=C[DN73F7,^=7>MI<EHW5XRMKZCY>5))J=W=WTL[<MHV333O=\SO=
M64;-RS?'VJQ:/HEG<3ZW8:%NUO1XC>7VLV6@02HMR+B[MDN[^\MXW9[*WNG-
MN)&=TBD`5@IKZ#AS!SQN/K4J>7ULPY<+B9*E1PM7%SBW3Y*<W3HTJDDHU9TU
M[5Q483E&\HW1*E&G"'M9QB_:X.[^%.,<9AIXBR;=D\/&M>',W.'-3]]RM+P[
M3]6\.02>'-_Q,T6272I;;45O-7^+5MJQMM8N/`^J6&HSW/VGQ3/)=VG_``D!
MTY3:!9+<">X\F$07%QYGZ!B<%FDXYGR\*8J$,7&I0=+#<.SPW/AH9KAZU&$.
M3`4XTZGU/VS59N-9N-/VM1U:='E\[#N*67+$U>91C@ZF)7ME?VU-8[V_*U45
MK\^'C)4G&G4B^76*J)<[JOC/2!I%I%+XJM9;(ZWHS'2;_P")/AWQ-KAUB&QN
M4OM:M=03Q'?0Z?ILER\+Z<UQ<6UOI^I6]IJ$D&G11&6#T\'D6-^NUI0R>I3K
MK"XE+$4<CQN`PBPTJL'2PM2B\%AYUJ\8*2QBI4JM;&8*=;!PJXVI/V=12J25
M"O&5>$INE3C5?-"=.M6C#%MSI4;22HRQ;R^;I^QI0<*515,/&C[959++QAX>
M%]J4H\21Z:9$3[592_%71+GQ+X@\.QZ[$]EIUKXRB\62VMA=:=8*K1PW&OVU
MV[ZOK"1OY7^G7DU\CS+ZOA8?V7+$\K?LZL>'\53P.#QLL))5:U3+)9="M6IX
MJLVISI9;5P\8X?`SG'VG^RT'*</:MTZGL[0FJ;JU54M"3RYUJ49\]5P<G3QC
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M`!#UN;5]*2R,\/V*6_\`$7EM!<(MM)'/"\>F/R.M.>-E@>'ZE!SHTU5=7AS&
M5E7C&A5ISI8)4<FP$,-B)5>2?MX8?+.=3I2E7A.G4A+-S?)67M/=<JG+%5HP
MFY/#86-"<92K57"G3KQQ3JQ=1QDZD9O"UX6ITW:/XMM_[7OFUGXA>&[FU'B/
M3=0_?^,O#3Z9=)9^*(;U;[2Y+WXJ:L]E'%I8FVVEMH?A^-DD4/"TD$2!8W)J
MGU+#K`<,XZC5^I5Z/N99CHUZ;JX"5)TJ\:7#^"C5E/$.-ZU7,,RG&2;C54*D
MY/2O/GJXB,:\/93E3<$IQY.2&8X*O34KU%RSH8:E5OR4+U)>TYZU>:I2J=9J
M7Q!\/W7B6*^M?&^CVZS6%JVE72?$_P`*6GA_0'-A?"_L_$OAZ+Q#-'K5\U[)
M#MEAL=17F(17=J(#(_C87AK,J&53P]7(,34=.M46(IO(<PJ8S&+VM+V-7`XR
M6#IRPM)4HRO">(PLOC=3#XAU%".[KT74PTI2_=+V/-"-6$)0FJ[EB)5&II2A
M/#.%*,5*LN>$^6-"4UB7R<7B?3+RP-O_`,+"BTFU4R2M:7OQFT2XU>?5X?#6
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MKY0ZPH`*`"@`H`*`"@`H`*`"@`H`*`"@`H`*`"@`H`*`"@`H`*`"@`H`*`"@
M`H`*`"@`H`*`"@`H`*`"@`H`*`"@`H`*`"@`H`*`"@`H`*`"@`H`*`"@`H`*
M`"@`H`*`"@`H`*`"@`H`*`"@`H`*`"@`H`*`"@`H`*`"@`H`*`"@`H`*`"@`
EH`*`"@`H`*`"@`H`*`"@`H`*`"@`H`*`"@`H`*`"@`H`*`/_V3\_
`
end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
